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An outline 
 
In this section I am giving a brief account of thesis structure. This thesis 
represents a culmination of work and learning that has  taken place over a 
period of three years at the Istitute of Biostructure and Bioimaging of Naples. 
In my Ph.D. project I focus my attention on proteins involved in cell wall division 
and regulation of revival from dormancy in different kind of bacteria. 
In the following section of this thesis there is a part dedicated to A GENERAL 
OVERVIEW on bacterial cell wall composition and biosyntesis. In this context, I 
also introduce the main molecular players in bacterial cell wall division and 
resuscitation from dormancy. Following the general overview, this thesis consists 
of two parts, PART I and PART II, describing two different aspects of cell division 
that have been investigated during my Ph.D. work. 
PART I describes structural and functional studies of RipA, an enzyme essential 
for cell division in Mycobacterium tuberculosis, and of its inactive mutants. 
PART II describes structural and functional investigations on two proteins 
involved in regulation of cell wall division and resuscitation form dormancy, the 
serine/threonine kinases PrkC from Staphylococcus aureus and Bacillus subtilis 
and the Penicillin Binding Protein PonA2 from Mycobacterium tuberculosis. 
I would like to take this opportunity to thank my supervisors, Prof. Gabriella 
D’Auria and Dr. Rita Berisio and the other members of the Istitute of Biostructure 
and Bioimaging of Naples for providing an extremely stimulating atmosphere 
to work in. 
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A GENERAL OVERVIEW: Bacterial cell wall 
composition and modeling 
 Bacterial cell wall 
The bacterial cell wall is an elastic macromolecule that defines the shape of 
bacteria and enables them to resist lysis (Johnson et al., 2013). Despite an 
essential structural role, the bacterial cell wall is highly dynamic and intimately 
involved in a broad range of cellular processes, including growth and division, 
chromosome segregation, morphogenesis, interaction between the bacterium 
and its environment, biofilm formation, pathogenesis, homeostasis of the 
membrane-proximal ionic environment and movement of material in and out 
of the cell (Archibald et al., 1993). These dynamic processes must occur 
without compromising cell wall integrity, which would lead to lysis and death. 
Cell wall containing bacteria fall into two groups, Gram-positive and Gram-
negative, based on fundamental difference in the cell envelope structure. A 
few species, such as Mycobacteria, are difficult to classify as they have a 
unique envelope composition. Peptidoglycan (PG) is a key structural 
constituent of bacterial cell walls. It is present in all bacteria with the exception 
of Mycoplasma, Planctomyces and a few other bacterial species that lack a 
cell wall (Moulder, 1993; Seltmann and Holst, 2002). The chemical composition 
of PG in Gram-negative and Gram-positive bacteria is similar, with a few 
differences which will be described below. 
 Gram-negative cell wall 
In electron micrographs, the gram-negative cell wall appears multilayered. It 
consists of an outer membrane (OM) that surrounds a thin PG layer of a few 
nanometers (2-3nm) embedded in a periplasmic space between the plasma 
membrane (PM) and the OM (Figure 1). Chemically, only 10 to 20% of the 
gram-negative cell wall is PG. The PG layer is covalently attached to the OM 
by the lipoprotein called Lpp or Braun´s lipoprotein (Braun, 1975). The OM of 
the gram-negative cell wall appears as a lipid bilayer which is composed of 
phospholipids, lipoproteins, lipopolysaccharides (LPS), and proteins. In addition, 
pore-forming proteins called porins span the OM (Figure 1). Porins function as 
channels for the entry and exit of solutes through the outer membrane of the 
gram-negative cell wall.  
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 Gram-positive cell wall 
A gram-positive cell wall is primarily composed of a thick layer PG which 
accounts for 30-70% of the total cell wall mass, compared with just 10-20% in 
Gram-negatives (Shockman and Barrett, 1983). It does not possess an OM and 
it contains large amounts of anionic polymers called teichoic acids (TAs) 
(Figure 1), which confer them a negative charge.  TAs are covalently attached 
to the PG layer (wall teichoic acids, WTAs) or anchored to the cytoplasmic 
membrane (lipoteichoic acids, LTAs). Additional surface structures may also be 
present in both Gram-positive and Gram-negative species. These structures 
include pili, capsulae, fimbriae and flagella (Beveridge and Graham, 1991). 
 
Figure 1. General structure of the Gram-positive and Gram-negative cell wall 
 Chemical composition of peptidoglycan  
PG is a complex heteropolymer which consists of long glycan strands cross-
linked by short peptide bridges, to form a large molecule of strong but elastic 
nature (Höltje, 1998; Park, 1996; Weidel and Pelzer, 1964). The glycan strands 
are formed by N-acetylmuramic acid (MurNAc) and N-acetylglucosamine 
(GlcNAc) linked by β-1,4 glycosidic bonds. Glycan chain length varies 
considerably between organisms, from about 6 disaccharides (e.g. in 
Staphylococcus aureus) to a maximum length of 500 disaccharides (e.g. in 
Bacillus subtilis) (Ward, 1973; Hayhurst et al., 2008). The peptide stems are much 
less conserved than the glycan strands and are composed of tetrapeptides (L-
Ala, γ D-Glu, diamino (DA), D-Ala) covalently attached to the lactyl group of 
MurNAc by L-alanine N-terminus (Figure 2). The presence of D-amino acids is 
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an almost unique feature of bacteria and plays a role in conferring resistance 
against host proteases. 
PG tetrapeptides are linked together by covalent bonds between the DA 
group of one stem and the D-Ala residue of the crosslinking stem (Figure 2). The 
DA residue is commonly a meso-diaminopimelic acid (m-DAP), a dibasic 
amino acid, or an L-Lys residue. Most Gram-positive bacteria (e.g. S. aureus) 
contain an L-lysine residue at the third position of the stem peptide, whereas 
Gram-negative bacteria (e.g. Bacillus species) and most endospore formers 
have an m-DAP residue at this position (Shah et al., 2008). 
 
Figure 2. The chemical structure of peptidoglycan. A typical PG disaccharide 
pentapeptide. The glycan strand is composed of a repeating disaccharide of the amino 
sugars GlcNAc and MurNAc (Yellow) linked by β-1,4 glycosidic bonds (green). The 
pentapeptide is covalently linked to the glycan strand via the lactyl group of MurNAc (pink). A 
typical pentapeptide stem composition is shown, although the precise composition is variable. 
 Peptidoglycan turnover, bacterial cell wall growth and division 
The process of PG cell wall turnover was discovered fifty years ago, when DAP 
was found to be released from the cell wall of the bacterium Bacillus 
megaterium during exponential growth (Chaloupka, 1962a, 1962b). Later on, 
pulse-chase experiments with radioactively labeled cell wall precursors such as 
GlcNAc or D-glutamic acid revealed that Gram-positive species turn over up 
to 50% of their PG in each generation during vegetative growth (Rogers 1967; 
Mauck et al., 1971; Boothby et al., 1973; Doyle et al., 1988). Based on the 
“inside-to-outside” growth model of Gram-positive bacteria, new PG cell wall 
are laid down along the cytoplasmic membrane and, at the end of the 
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turnover cycle, removed from the exterior by autolysins (Merad et al., 1989; 
Pooley, 1976). Therefore, inner regions of the cell wall contain newly 
synthesized, unstressed PG. As the cell elongates, this material passes outward 
and stretches, becoming the middle, stress-bearing zone. The outer zone may 
thus consist of old, partially hydrolysed PG awaiting solubilization (Graham & 
Beveridge, 1994). This “inside-to-outside” model of wall structural dynamics 
suggests that autolysins are necessary for hydrolysis of older PG to allow newer 
PG to expand and become stress-bearing as the cell elongates. The “inside-to-
outside” model for cell-wall growth suggests that breakage of covalent bonds 
within the PG is essential for cell growth.  
Bacterial cell growth and cell wall division are mediated by a collection of 
proteins whose action is tightly coordinated at the level of the septal ring 
(Nanninga 1998). In E. coli, cell division takes place at the mid-cell after the 
chromosomal replication and segregation into two daughter nucleoids. After 
the completion of chromosome segregation, the division process begins with 
the formation of the septal ring, called Z-ring, a polymer of the tubulin-like 
protein FtsZ (Dajkovic et al., 2006; Lutkenhaus et al., 1980). FtsZ is almost 
universally conserved and has also been identified in Mycobacterium 
tuberculosis (MTB) as one of the major cytoskeletal organizers of the 
mycobacterial divisome (Hett and Rubin, 2008; Dziadek et al., 2003). The 
depletion of FtsZ from bacteria results in long filamentous cells (Lutkenhaus et 
al., 1980). The ring formed by FtsZ involves the highly ordered recruitment of 
both structural and enzymatic proteins involved in PG synthesis and thus in the 
formation of the septum (Margolin, 2005).  
 Molecular players in bacterial cell division and exit from 
dormant state 
Septal PG  is initially shared between daughter cells and must be degraded by 
PG hydrolases to complete the division process. Although as many as 18 
hydrolases are known to be involved in septum cleavage of E. coli, only few of 
them are known in mycobacteria, which possess a unique envelope structure 
with additional layers of arabinogalactan and mycolic acids (Hett et al., 2008; 
Brennan, 2003). Cell separation is mediated in MTB by the essential NlpC/P60 
endopeptidase Resuscitation Promoting factor Interacting Protein A (RipA), 
which cleaves peptidoglycan peptide crosslinks  (Hett et al., 2008), similar to 
other cell separating endopeptidases, like CwlT from B. subtilis (Fukushima et 
al., 2008) and Spr from E. coli (Aramini et al., 2008). RipA has a remarkable 
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effect on the bacterial phenotype, since ripA depletion strains in M. smegmatis 
exhibit a decreasing growth and an abnormal phenotype, consisting of 
branching and chaining bacteria (Hett et al., 2008). Interestingly, RipA co-
localizes at bacterial septa with the Resuscitation Promoting Factor RpfB 
(Ruggiero et al., 2010), a key cell wall hydrolase involved in MTB resuscitation 
from a state of low metabolism denoted as dormancy (Mukamolova et al., 
2002; Kaprelyants et al., 2012; Ruggiero et al., 2012; Ruggiero et al., 2011). The 
combined action of RpfB and RipA seems to enhance PG hydrolysis, this 
suggesting that an interaction between the two molecules may positively 
regulate their catalytic functions. 
 Bacterial Serine/Threonine Protein Kinases and Penicillin 
Binding Proteins: Regulation of cell division 
Protein kinases are classified into two families based on their similarities and 
enzymatic specifications, including the histidine kinase superfamily (Stock et al., 
1989), the serine/threonine and tyrosine kinase superfamilies (Hanks et al., 
1988). Histidine kinases represent the classical prokaryotic mechanism for 
detection and response to environmental changes, whereas the 
serine/threonine and tyrosine protein kinases have recently emerged as 
important regulatory systems (Shah et al., 2010; Pereira, S.F., 2011; Wehenkel et 
al., 2008). 
Serine/threonine protein kinases (STPKs) have been shown to regulate process 
of cell division (Shah et al., 2010); Their wide distribution in bacterial genomes 
suggests that STPKs regulatory function in cell shape and division is widely 
preserved among prokaryotes. Recent progress has been made to elucidate 
the biological function of StkP in S. pneumoniae and B. subtilis cell division. The 
kinase StkP from S. pneumoniae is essential for bacteria survival and virulence 
(Echenique et al., 2004) and it localizes at the cell division sites. In B. subtilis, the 
kinase PrkC is responsible for resuscitation from dormancy induced by the 
presence of PG fragments in the bacterial milieu (Shah et al., 2008). Similarly, 
bacterial resuscitation has also been shown to be regulated in MTB by PonA2, 
a protein belonging to the Penicillin Binding Protein (PBP) family and classically 
associated to PG synthesis (Patru et al., 2010). 
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PART I - Structure and Functional Regulation of RipA, 
a Mycobacterial enzyme essential for cell division 
I.1 AIM OF THE STUDY 
The final stage of bacterial cell division depends on cell-wall hydrolases that 
cleave the PG layer connecting daughter cells. In MTB, this process is governed 
by the predicted endopeptidase RipA. In the absence of this enzyme, the 
bacterium is unable to divide and exhibits an abnormal phenotype. This makes 
RipA an excellent candidate as a drug target against Tuberculosis (TB). We 
here report the crystal structure of a relevant portion of RipA, containing its 
catalytic-domain and an extra-domain of hitherto unknown function. The 
structure clearly demonstrates that RipA is produced as a zymogen, which 
needs to be activated to achieve cell-division. Bacterial cell-wall degradation 
assays and proteolysis experiments strongly suggest that activation occurs via 
proteolytic processing of a fully solvent exposed loop identified in the crystal 
structure. Indeed, proteolytic cleavage at this loop produces an activated 
form, consisting of the sole catalytic domain. This work provides the first 
evidence of self-inhibition in cell-disconnecting enzymes and opens a field for 
the design of novel anti-tubercular therapeutics. The aim of this study was to 
clone, express, purify and characterize the predicted endopeptidase RipA 
from MTB. We have investigated RipA function both structurally and 
biochemically by combining atomic structure characterization, circular 
dichroism (CD), fluorescence spectroscopy and  mass spectroscopy. 
Broken down, the aims were: 
 Identification of well-structured RipA variants by a combination of 
different bioinformatic investigations; 
 Establishing purification protocols for different RipA variants; 
 Identify of best crystallization conditions by robotic procedure; 
 Optimizing the crystallization conditions by manual procedure; 
 Optimizing cell wall degrading assay; 
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I.2 BACKGROUND - Tuberculosis, old disease, new danger 
TB is more prevalent in the world today than at any other time in human history. 
This kind of infectious bacterial disease is caused by MTB. Each year, 
approximately 2 million persons worldwide die of TB and 9 million become 
infected. TB remains a leading cause of mortality worldwide due to the ability 
of MTB to survive in a dormant status for extended periods of time in humans 
without producing symptoms for subsequently reviving into an active state. 
(Yukari C. et al., 2000). This apparent dormancy can develop into active 
disease even decades after initial infection, when the immune response 
diminishes, as in the case of TB-HIV co-infection (Yukari C. et al., 2000, Nancy 
A., Knechel, 2009).  
MTB is a rod-shaped, non-spore forming, aerobic bacterium which typically 
measure 0.5µm by 3µm (Figure 3). It is classified as acid-fast bacillus and have a 
unique cell wall structure crucial to its survival. The cell wall complex contains 
PG, but otherwise it is composed of complex lipids. Over 60% of the MTB cell 
wall is lipid. The cell wall contains also mycolic acid, covalently attached to the 
underlying PG-bound polysaccharide arabinogalactan, providing an 
extraordinary lipid barrier. This barrier is responsible for many of the medically 
challenging physiological characteristics of TB, including resistance to 
antibiotics and host defense mechanisms. 
 
Figure 3. Mycobacterium tuberculosis scanning electron micrograph 
Approximately 30% of exposed people become infected; 60-90% of these 
people will have an effective immune response allowing the successful 
containment of the infection. As more T cells, monocyte and macrophages 
are recruited to the area surrounding the bacilli, the bacilli slow replication and 
wait patiently, unable to transmit infection. During this phase the MTB survives in 
a state of minimum metabolism that allows it to escape the immune system 
  
18 
 
attacks and traditional drug therapy (Yukari C. et al., 2000). It is estimated that 
approximately one-third of the world’s population is infected with MTB (WHO, 
Global Tuberculosis Control, 2010). TB in a latent state is very dangerous 
because persons with latent TB have no signs or symptoms and diagnosis is 
difficult. The reactivation of latent TB depends on many factors such as the 
virulence of the organism, the competence of host defenses and the presence 
of other diseases (diabetes, HIV infection) or immunosuppressive therapy 
(Kaufmann SH., 2008; Keep NH et al., 2006). 
Treatment for active TB usually combines several different antibiotic drugs that 
are given for at least six months, sometimes for as long as 12 months. The 
principal drugs are: Rifampicin, Isoniazid, Pyrazinamide, Ethambutol. 
Associations of three drugs of first-line (Rifampicin, Isoniazid and Pyrazinamide) 
are recommended for the treatment of the intensive phase of TB, whereas 
associations of Rifampicin and Isoniazid are recommended for the 
continuation phase of the disease. Unfortunately, however, the treatments 
incomplete or inadequate has led to the emergence of strains resistant to 
antibiotics. Multidrug-resistant TB (MDR-TB) is defined by resistance to the two 
most commonly used drugs in the current four-drugs (or first-line) regimen, 
Isoniazid and Rifampin. MDR-TB must be treated necessarily with second-line 
drugs (Ethionamide, Cycloserine, Capreomycin). According to the WHO, 
Eastern Europe's rates of MDR-TB are the highest, where MDR-TB makes up 20 
percent of all new TB cases. In some parts of the former Soviet Union, up to 28 
percent of new TB cases are Multidrug-resistant (http://www.tballiance.org). 
Complications due to prolonged treatment with antibiotics, as well as the 
emergence of MDR-TB and the inability to treat latent TB gave a strong impetus 
to research and design of novel anti-tubercular drugs. In this contest, RipA 
would be an excellent new candidate as a drug target against TB. 
I.3 EXPERIMENTAL PROCEDURES 
Here, we report the cloning, expression, purification, crystallization, 
crystallographic and functional investigations of a relevant portion of RipA 
(RipA263-472), containing its predicted catalytic domain (residues 355-471) and 
the PB015164 domain (residues 265-354), as identified in the Protein Families 
(PFAM) database (Finn R.D. et al., 2008). 
I.3.1 Cloning and expression of RipA variants 
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Oligonucleotide primers were synthesized by Primm (Milano, Italy) and were 
designed to amplify the nucleotide sequence corresponding to the three 
variants of RipA by Polymerase Chain Reaction (PCR) using genomic DNA of 
MTB as a template (H37Rv strain) (Figure 4A). NcoI/HindIII-digested fragments 
were cloned into the pETM-11 (Figure 4B), pETM-30 (Figure 4D) and pETM-20 
(Figure 4C) expression vectors (Novagen, Wisconsin, USA) for RipA40–472, RipA263-
472 and RipA332–472, respectively. The pETM20 vector contains the stabilising TRX 
fusion tag, whereas the pETM30 vector allows the expression of GST-fusion 
proteins1. The resulting positive plasmids of RipA40–472 and of RipA263-472 were 
used to transform E. coli BL21(DE3) strain (Invitrogen, California, USA) while the 
resulting positive plasmid of RipA332–472 was used to transform BL21 Star(DE3) 
strain2. The expression of RipA variants were carried out using the transformed 
cells grown overnight at 37°C in Luria-Bertani (LB) media containing the 
opportune antibiotics and then inducing them overnight with 1 mM Isopropil β-
D-1-tiogalattopiranoside (IPTG) at 22°C. 
 
A B 
                                            
1 Novagen pET expression system is the most popular commercial expression system for E. coli 
and is based on the T7 promoter (Yin et al., 2007). It represents more than 90% of the 2003 PDB 
protein preparation systems (Sørensen and Mortensen 2005). The pET system was first described 
in 1990, and has been developed for a variety of expression applications (Studier et al., 1990; 
Dubendorff and Studier 1991). 
2 Escherichia coli represents the ideal expression system of choice for the majority of 
laboratories engaged in high-throughput cloning, expression and purification of proteins for 
structural genomics (Goulding, C.W., Perry, L.J., 2003). 
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C D 
 
Figure 4. Genome of H37Rv strain and pETM vectors maps. A) Genomic DNA of MTB; 
B) pETM11 vector map; C) pETM20 vector map; D) pETM30 vector map; 
I.3.2 Purification of RipA variants 
The same procedure of purification was applied to all RipA variants. A 1 Liter 
expression cell pellet of each RipA variants was re-suspended in 30 mL of 
binding buffer (10 mM imidazole, 150 mM NaCl, 50 mM TrisHCl, pH 8.0), 
containing a protease-inhibitor cocktail (Roche Diagnostic), and sonicated for 
10 minutes with intervals during the procedure in order to avoid protein 
degradation due to heat produced by the sonicator’s sound waves. The 
lysates were cleared by centrifugation at 18,000 rpm for 40 minutes at 4°C. The 
supernatants were loaded on a 5-mL Ni2+-nitriloacetic acid (NTA) column 
(Pharmacia), equilibrated with binding buffer, and purified by immobilized 
metal affinity chromatography (IMAC). After washing with 10 volumes of 
binding buffer, a linear gradient of imidazole (5-300 mM) was applied to elute 
the proteins (Figure 5). 
 
Figure 5. Affinity chromatography chromatogram of RipA 
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The 2 mL fractions containing RipA variants were brougth to a final volume of 
20 mL with a buffer containing 50mM Tris-HCl, 150 mM NaCl (pH 8.0) and kept 
under TEV protease digestion at 20°C overnight. After removal of tag, RipA40-472 
and RipA263-472 were further purified by size exclusion chromatography on 
Superdex 200 (Pharmacia) (Figure 6) with a buffer containing 50 mM TrisHCl, 
150 mM NaCl, 5% glycerol (pH 8.0), whereas RipA332-472 was purified on 
Superdex 75 (Pharmacia) with the same buffer. The proteins eluted in a single 
peak and were homogeneous as judged by SDS–PAGE analysis. The molecular 
mass were checked by mass-spectroscopy. Fresh concentrated proteins, 
usually 7-10 mg/mL, were used for crystallization experiments. 
 
Figure 6. Gel filtration chromatogram of RipA263-472 
I.3.3 Crystallization experiments 
We used high-throughput robotic systems to screen and optimise crystallisation 
conditions of RipA variants. The initial screening involves the high throughput 
crystallization screening robot (Hampton) and commercially available sparse-
matrix kits (Crystal Screen kits I and II, Hampton Research) and utilizing the 
hanging-drop vapor diffusion technique. The Hampton robot was utilized to 
create the hanging drops containing the protein solution and crystallizing 
buffer in 1:1 ratio. After protein and buffer administration, the plates were 
sealed and stored at 20°C. Crystal formation was observed with a light 
microscope. 
The initial screenings revealed several promising conditions for crystallization of 
RipA263-472 variant. All favourable conditions were characterized by the 
presence of PEG4000 as precipitating agent. The quality of the crystals was 
improved by fine-tuning the concentration of the protein and of the 
precipitants. 
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I.3.4 Production of selenomethionine-labeled RipA263-472 
A SeMet derivative of the protein was prepared to perform Multi-wavelength 
Anomalous Diffraction (MAD) experiments. Seven methionines are present in 
the sequence, which consists of 210 residues. For the preparation of labeled 
protein of RipA (SeMetRipA263-472), the E. coli BL21(DE3) cells expressing the 
recombinant enzyme were grown in 1 L of minimal media (M9) containing 0.4% 
Glucose, 1 mM MgSO4, 0.1 mM CaCl2, 50 ugL-1 kanamycin, 100 ugL-1 thiamine 
at 37°C. After reaching the OD600 of 0.7, an aminoacid mix (50 mg L-1 Ile, Leu 
and Val and 100 mg L-1 of Phe, Thr, and Lys) was added to the culture to inhibit 
methionine biosynthesis in E. coli then shifted to 22°C. After about 15 minutes, 
60 mg L-1 of seleno-L-methionine were added and the induction was 
performed. The same purification protocol as for the native protein was used 
for the labeled protein. Crystals of SeMetRipA263-472 grew in similar conditions as 
the native protein. 
I.3.5 RipA mutants preparation 
The expression vectors encoding the C383A, H432A, E444H mutations were 
generated by site-directed mutagenesis of wild-type plasmids pETM20-RipA263-
472 and pETM-20-RipA332–472 using the Stratagene QuikChange kit and the 
mutagenic primers reported below. 
 
 
C383A 
 
5'-CCGTCGGCTTCGACGCCTCAGGCCTGGTGTTG-3' 
5'-CAACACCAGGCCTGAGGCGTCGAAGCCGACGG-3' 
 
H432A 
 
5'-CCGAACGGTAGCCAGGCCGTGACGATCTACCTC-3'  
5'-GAGGTAGATCGTCACGGCCTGGCTACCGTTCGG-3' 
 
E444A 
 
5'-CAACGGCCAGATGCTCGCGGCGCCCGACGTCGG-3' 
5'-CCGACGTCGGGCGCCGCGAGCATCTGGCCGTTG-3’ 
 
Introduction of the expected mutations was confirmed by DNA sequencing. 
Expression and purification of the mutants were carried out in the same 
conditions as for their unmutated enzyme. 
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I.3.6 Data collection and processing of RipA263-472 
Preliminary diffraction data were collected in-house at 100K using a Rigaku 
Micromax 007 HF generator producing Cu Kα radiation and equipped with a 
Saturn944 CCD detector. Higher diffraction data for both native RipA263-472 
(Figure 7) and SeMetRipA263-472 were collected at the synchrotron beamline BM14 
at the ESRF (Grenoble, France) at 100 K. Cryoprotection of the crystals was 
achieved by a fast soaking in a solution containing glycerol to a final 
concentration of 30% (v/v). MAD was carried out using three different 
wavelengths determined from the selenium absorption spectrum. A native 
dataset was also recorded. The data sets were scaled and merged using 
HKL2000 program package (Otwinowski, Z. et al., 1997). 
 
Figure 7. Diffraction pattern of native RipA crystal. Diffraction data are detectable to 
0.95 resolution. 
I.3.7 Crystallization, data collection and processing of RipA263-472 
mutants 
Crystallization trials were performed at 293 K using the hanging-drop vapor-
diffusion method. Best crystals were obtained using 5–10 mgxmL-1 protein 
solution and 8% (v/v) 2-Propanol, 16% (w/v) PEG4000 in 60 mM sodium citrate 
trihydrate buffer, pH 5.6. Diffraction data of the H432A mutant were recorded 
inhouse at 100K using a Rigaku Micromax 007 HF generator producing Cu Kα 
radiation and equipped with a Saturn944 CCD detector whereas diffraction 
data of the C383A mutant were collected at the synchrotron beamline BM14 
at the ESRF (Grenoble, France). Cryoprotection of the crystals was achieved by 
a fast soaking in a solution containing glycerol to a final concentration of 30% 
(v/v). The data sets were scaled and merged using HKL2000 program package 
(Otwinowski and Minor, 1997). 
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I.3.8 Structure determination of RipA263-472 
The structure of the enzyme was solved by MAD methods using the anomalous 
signal from the Se atoms of selenomethionine-labeled protein. In order to 
determine the peak and the inflection wavelengths, a fluorescence scan was 
recorded on a single SeMet-labeled RipA263-472 crystal. Using data sets 
collected at wavelengths optimized for SeMet, the program SOLVE (Terwilliger, 
T.C., Berendzen, 1999) identified five selenium sites in the asymmetric unit of the 
protein. The program SOLVE provided a set of initial phases, which were 
improved using the solvent flattening methods implemented in the program 
RESOLVE (Terwilliger, T.C., 2003) and wARP (Langer, G. et al., 2008). Using these 
phases and atomic resolution data from a native crystal (1.0 Å, Figure 7), nearly 
90% of the residues present in the asymmetric unit could be automatically 
modeled using the program wARP. Model building was optimized using both 
automatic and manual approaches (Jones, T.A., 2004). Crystallographic 
refinement was first carried out against 95% of the measured data using the 
CCP4 program suite (Potterton et al., 2003). The remaining 5% of the observed 
data, which was randomly selected, was used in Rfree calculations to monitor 
the progress of refinement. The refinement in Refmac was started using data 
up to 1.7Ă resolution and gradually increased in subsequent rounds of 
refinement to the highest resolutions (Murshudov et al., 1997). At this stage, 
water molecules were incorporated into the structure in several rounds of 
successive refinement. This refined model was used to carry out CGLS 
refinement using SHELXL97 (Sheldrick, 2008), where X-ray intensities were used in 
refinement calculations. Structures were validated using the program 
PROCHECK (Laskowski et al., 1996). 
I.3.9 Structure refinement of mutants 
The structures of RipA263-472C383A and RipA263-472H432A were refined against the 
structure of RipA263-472. Crystallographic refinement was carried out against 95% 
of the measured data using the CCP4 program suite (Potterton et al., 2003). 
The remaining 5% of the observed data, which was randomly selected, was 
used in Rfree calculations to monitor the progress of refinement. The refinement 
in Refmac was started with rigid body refinement, followed by restrained 
refinement (Murshudov et al., 1997). Water molecules were incorporated into 
the structure in several rounds of successive refinement. In the case of the 
C383A mutant, whose crystals diffracted at atomic resolution, CGLS refinement 
  
25 
 
cycles were performed using SHELXL97 (Sheldrick, 2008). Initial rounds of 
restrained CGLS refinement were carried out by keeping all atomic 
displacement parameters (ADPs) isotropic. Subsequently, the ADPs were 
converted to anisotropic values, leading to improved Fourier maps. The bulk 
solvent was modeled based on Babinet’s principle, as implemented in the 
SWAT option in the SHELXL program. An approximate isotropic behaviour was 
attributed to solvent atoms (ISOR restraint). The final round of refinement was 
carried out with the inclusion of riding H atoms for protein residues. The positions 
of H atoms assigned based on the known geometrical criteria were not 
refined. Structures of C383A and H432A were validated using the program 
PROCHECK (Laskowski et al., 1996). 
I.3.10 Circular Dichroism studies 
All CD spectra were recorded with a Jasco J-810 spectropolarimeter equipped 
with a Peltier temperature control system (Model PTC-423-S). Molar ellipticity 
per mean residue, [θ] in deg cm2 x dmol-1, was calculated from the equation: 
[θ] = [θ]obs x mrw x (10 x l x C)-1, where [θ]obs is the ellipticity measured in 
degrees, mrw is the mean residue molecular mass, C is the protein 
concentration in g x L-1, and l is the optical path length of the cell in cm. Far-UV 
measurements (183–250 nm) were carried out at 20°C using a 0.1 cm optical 
path length cell and a protein concentration of 0.2 mgxmL-1. 
I.3.11 Limited proteolysis experiments 
RipA263–472 variant was incubated at room temperature with trypsin, thermolysin, 
and pronase at various protease/enzyme ratios (1:50, 1:100, 1:200, and 1:500) in 
a suitable buffer containing 50 mM Tris/HCl pH 8 and 10 mM CaCl2. Samples 
were taken after 30 and 90 minutes and the reactions stopped by adding SDS- 
PAGE sample buffer. The reaction products were analyzed by SDS-PAGE. 
Samples were also analyzed by mass spectrometry, after trypsin (1:50 ratio), 
thermolysin (1:100 ratio), and pronase (1:500 ratio) digestion. 
I.3.12 Mass spectrometry studies 
Mass Spectrometry (MS) analysis was carried out on an LCQ DECA XP Ion Trap 
mass spectrometer (ThermoElectron, Milan, Italy) equipped with an OPTON ESI 
source (operating at 4.2-kV needle voltage and 320°C), and with a complete 
Surveyor HPLC system. Narrow bore 50 x 2 mm C18 BioBasic Liquid 
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Chromatography-Mass Spectrometry (LC-MS) columns from Thermo- Electron 
were used for the analyses. LC binary gradient was from 5% to 70% of B (where 
B was CH3CN 0.05% TFA, and A H2O 0.08% TFA) in 45 minutes. Initial protein 
concentration was 22 µM (0.5 mgxmL-1). Three microliters of this solution were 
injected for all analyses. Mass spectra were recorded continuously between 
the mass range 400–2000 Da in positive mode. Multicharge spectra were 
deconvoluted using the BioMass program implemented in the Bioworks 3.1 
package provided by the manufacturer. 
I.3.13 Cell wall degradation assays 
Inactivated lyophilized cells of M. lysodeikticus (ATCC No. 4698) were labeled 
with fluorescein isothiocyanate (FITC) by covalently linking FITC to amine 
groups in the cell wall. In this reaction, 40 mg cells were incubated at 20°C with 
20 mg FITC (50 mgxmL-1) in 100 mM NaCO3, pH 8.5, protected from light. After 
16 hours incubation, the reaction mixture was centrifuged; the insoluble 
material was washed until the supernatant was completely colorless, to 
eliminate unreacted fluorochrome. The labeled insoluble material was re-
suspended and stored at -20°C in a 4X reaction buffer (50 mM Tris-HCl, 10 mM 
MgCl2, 2 mM MnCl2, 100 mM NaH2PO4, 50 mM KCl, 0.01% (v/v) CHAPS). RipA263–
472, RipA332–472 and RipA332–472C383A, RipA332–472H432A, RipA332–472E444H mutants 
were incubated with FITC-labeled cells at 30°C in the reaction buffer; the 
insoluble substrate was centrifuged (16,000 x g) and soluble FITC conjugates 
were measured in triplicate with filters for excitation at 492 nm and emission at 
518 nm. The buffer alone was used to correct for background release of FITC. 
I.3.14 Modeling studies and bioinformatics analyses 
The conformation of the muropeptide GlcNAc-MurNAc-L-Ala-γ-D-Glu-
mesoDAP-D-Ala was modeled in the RipA binding cleft using the program 
INSIGHT. The position of L-Ala-γ-D-Glu moieties of the muropeptide was locked 
to that observed in the structure of its complex with endopeptidase YkfC from 
Bacillus cereus (28.6% identity with RipA catalytic domain) (Xu, acta 2010). The 
resulting model was energy minimized using GROMACS (Lindahl et al., 2001). 
Sequence conservation studies were carried out using the software ConSurf. 
The homologue search algorithm CSI-BLAST was used to retrieve sequences 
from the UNIREF-90 sequence database (150 sequences). Sequences were 
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aligned using MAFFT-L-INS-I alignment method (minimal and maximal 
sequence identities were 35 and 95%, respectively). 
  
28 
 
I.4 - RESULTS AND DISCUSSION 
I.4.1 Structural studies 
In RipA sequence, four distinct regions can be identified (Figure 8): a signal 
peptide (orange) at its N terminus, two domains of unknown function denoted 
in PFAM-B as PB07342 (red) and PB015164 (green), which are mainly distributed 
in mycobacteria, and a predicted catalytic domain of the NlpC/P60 family at 
its C-terminus (purple). RipA catalytic domain contains a core of about 70 
amino-acid residues (residues 385-445) which shares a sequence identity of 
about 35% with cysteine proteases of the NlpC/P60 family. The PB010495 is 
instead both of unknown structure and function. 
 
Figure 8. Modular structure of RipA: PFAM prediction 
To reduce the overall complexity of the RipA protein, a systematic approach 
allowed the expression and purification of different RipA variants. In particular, 
selective domain truncation performed using a combination of different 
bioinformatic investigations like the prediction of secondary structure elements 
(PSIPRED, Jpred) (McGuffin et al., 2000; Cuff, J.A. et al., 1998), disordered 
regions (DISOPRED, PONDR) (Ward, J.J. et al., 2004; Xue, B. et al., 2010), coiled-
coils (PCOILS) (Gruber M. et al., 2006) and transmembrane regions (TMMHM) 
(Krogh, A., et al., 2001) or signal peptides (Bendtsen, J.D. et al., 2004). Based on 
these sequence analysis we have cloned and expressed three variants of RipA 
including: RipA deprived of its signal peptide (RipA40–472), a shorter variant 
containing both the PB015164 and the catalytic domains (RipA263–472), and the 
sole C-terminal catalytic domain (RipA332–472) (Figure 9). 
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Figure 9. RipA variants. RipA40–472 (red, green and purple domains), RipA263-472) (green and 
purple domains) and RipA332-472 containing the sole catalytic domain (purple domain). 
Crystals (Figure 10) suitable for X-ray diffraction data collection (0.2 x 0.2 x 0.4 
mm) were obtained for RipA263-472 and SeMetRipA263-472 using 7 mgxmL-1 protein 
solution and 8% (v/v) 2-Propanol, 16% (w/v) PEG4000, in 60 mM Sodium citrate 
trihydrate buffer, pH 5.6. 
 
Figure 10. Image of typical RipA crystals 
Statistics of data collection for RipA263-472 and SeMetRipA263-472 are reported in 
Table 1(pag. 66). Matthews coefficient calculations (Matthews, B.W., 1968) 
suggested the presence of one molecule per asymmetric unit (VM =1.77, with 
30.4% solvent content). The structure of the enzyme was solved by MAD 
methods using the anomalous signal from the Se atoms of selenomethionine-
labeled and refined at 1.1 Å resolution (Table 2, pag. 67). 
The overall crystal structure shows that its two domains, the catalytic NlpC/P60 
domain and the PB015164 domains identified in the PFAM database, are tightly 
bound (Figure 11). Surprisingly, we found that the catalytic site cleft of the 
enzyme is physically blocked by the PB015164 domain. This finding strongly 
suggests functional inactivity of the enzyme in this form and reveals a 
zymogenic nature for RipA. 
The structure of RipA catalytic domain comprises a central β sheet of six 
antiparallel β strands, a small two-stranded β sheet and six helices, arranged in 
a αββααββββββ topology. Its putative catalytic cysteine (Cys383) is located at 
the N-terminal end of a helix (a2) and is packed against the sixstranded β 
sheet core (Figure 12). At this location, Cys383 facets another conserved 
residue, His432, belonging to the β strand β3 (Figure 12). This histidine is 
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hydrogen bonded to the side chain of Glu444, which is in turn tightly anchored 
to Arg453 and Arg458 (Figure 12). Notably, the crystal structure shows that RipA 
contains a Cys-His-Glu catalytic triad, which is unusual in NlpC/P60 domains 
(Figure 13). A similar triad (Cys-His-Asp) characterizes another class of cysteine 
proteases involved in cell separation, denoted as Cysteine Histidine Amino 
Peptidase (CHAP) domain containing proteases (Bateman and Rawlings, 2003; 
Rossi et al., 2009). 
 
Figure 11. The crystal structure of RipA263–472 shows self-inactivation 
 
Figure 12. Topology of RipA catalytic domain and zoom of the catalytic site 
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Figure 13. Multiple Sequence Alignment of NlpC/P60 Domains Identified by 
CONSURF Conserved Cys and His are highlighted in dark grey, the third catalytic residue is 
shown in light grey. 
As mentioned above, the crystal structure shows that RipA catalytic residues 
are not accessible to potential substrates (Figure 11), as they are locked by the 
PB015164 domain, here denominated pro-domain. A tight interaction between 
the catalytic domain and the pro-domain is observed, with a total interaction 
surface area of 1809 Å. Whereas the β hairpin is nearly completely solvent 
exposed (Figure 11), both the catalytic-cleftblocking loop region and the a 
helix, hereafter denoted as pro-a, establish several interactions with the main 
core of the RipA mature enzyme (Figure 11). Besides providing the first 
structural description of the pro-domain, our results elucidate its functional role. 
Using CD spectroscopy, we observed that the recombinant RipA332–472, lacking 
the pro-domain, is still able to fold (Figure 14). 
This finding suggests that the pro-domain is not needed for enzyme folding, as 
observed for proteases of the cathepsin family (Menard et al.,1998). Instead, 
the X-ray structure reported here highlights a role of the pro-domain as a 
regulator of the enzyme catalytic activity. With this concept in mind, we 
explored the possible mechanism that activates the zymogenic form of RipA 
and unlocks the catalytic site. A suggestion comes from the X-ray structure, 
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which displays a peculiarly long and fully solvent exposed loop connecting the 
catalytic- and the pro-domain. 
 
Figure 14. CD spectra of RipA263-472 (red) and of RipA332-472 (black) 
To investigate RipA vulnerability to proteases, we carried out limited proteolysis 
experiments by trypsin, thermolysin, and pronase whereas to investigate RipA 
activity we carried out cell wall degradation experiments using fluorescence 
spectroscopy. To elucidate the role of the putative catalytic triad in catalysis, 
we produced several mutants of RipA to repeat functional studies on bacterial 
cell wall and to investigate their crystal structure. 
I.4.2 Limited proteolysis experiments 
Using protease/enzyme concentration ratios of 1:500, these proteases were 
able to degrade RipA263–472 variant to fragments of about 15 kDa (Figure 15A) 
(see experimental procedures). This molecular weight, also checked by mass 
spectrometry, corresponded to the catalytic domain (RipA332–472 variant). 
Cleavage sites by these proteases were identified using LC-MS analysis. As 
shown in Figure 15A, all cleavage sites are located in the large and fully solvent 
exposed loop, which connects the catalytic NlpC/P60 domain and the pro-
domain. This shows that the connecting loop is a vulnerability point for the 
enzyme, as it is highly sensitive to proteolytic degradation (Figure 15B). In 
addition, LC-MS analysis shows that, after proteolysis at the connecting loop, 
the pro-domain is released and further proteolyzed. 
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Figure 15. Limited proteolisys studies and location of proteolytic cleavage sites 
A) Schematic representation of RipA domains, as defined by PFAM. The region that was found 
to be sensitive to degradation is indicated by a black box. The figure shows the mass spectra 
of main RP HPLC peaks after limited proteolysis of RipA263–472 with trypsin, themolysin, and 
pronase (cleavage sites are indicated) and the coomassie stained SDS-PAGE after limited 
proteolysis of RipA263–472 with trypsin, themolysin, and pronase. Molecular mass markers (Sigma, 
Low range) from the top to bottom: 45, 36, 29, 24, 20, 14.2, 6.5 kDa; B) Ribbon structure of 
RipA263–472 with proteolytic cleavage sites highlighted. 
I.4.3 Cell wall degradation experiments 
Cell wall degrading experiments were carried out using lyophilized cells of 
Micrococcus lysodeikticus labeled with FITC (see experimental procedures). 
Both recombinant RipA263–472 and RipA332–472 were incubated with the FITC-
labeled cells. PG hydrolyzing activity of RipA forms was evaluated by 
fluorescence spectroscopy as the amount of FITC-labeled cell wall released in 
solution. Fluorescence measurements of supernatants at time intervals allowed 
us to characterize the time course of cell degrading reaction. The most evident 
result is that RipA332–472 is able to degrade FITC-labeled cell wall because early 
incubation time intervals and its kinetics reaches a plateau after 20 hours 
(Figure 16A). By contrast, RipA263–472 displayed hardly any activity after 20 hours 
(Figure 16B). To investigate the role of the putative catalytic Cys383 in catalysis, 
we used mutant of RipA332–472C383A in the cell degrading experiments and we 
observed that its hydrolytic activity was completely suppressed (Figure 16C). 
The same suppression of RipA activity was observed on treatment of the 
enzyme with the sulfhydryl-alkylating reagent iodoacetamide (data not 
shown). 
B A 
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A B 
C 
Figure 16. Cell wall degrading activity of: A)RipA332–472, B) RipA263–472 and C) 
RipA332-472C383A. Values were measured as the amount of FITC-labeled cell wall released in 
solution on incubation with the enzymes. 
These results experimentally prove that RipA is a cysteine protease, as they 
demonstrate the fundamental role of Cys383 in catalysis. Furthermore, they 
confirm the result we derived from the X-ray structure that RipA exists as an 
inactive zymogen, and that removal of the pro-domain activates the enzyme. 
Because we observed some level of instability to proteolytic degradation of 
RipA variants produced, in particular on storage, we checked whether enzyme 
processing is an autocatalytic event, as observed for the lysosomal cysteine 
proteases cathepsins (Menard et al., 1998; Rozman et al., 1999; Wittlin et al., 
1999). To this aim, we carried out a typical assay for the assessment of self-
processing (Rozman et al., 1999), where the inactive mutant RipA263–472 (C383A) 
was incubated with the activated Rip332–472 form at room temperature. After 16 
hours, SDS-PAGE analysis showed that RipA332–472 is unable to process RipA263–
472C383A. This result unambiguously showed that RipA is not self-activated, but 
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it needs an activating mechanism. Thus far, it is unclear which mechanism is 
able to activate RipA. The strong susceptibility of the loop connecting the 
catalytic and prodomains to proteolytic degradation, as well as the tight 
interdomain interactions observed in the X-ray structure (Figure 11) strongly 
suggests that activation proceeds via proteolytic cleavage. However, 
because RipA is able to interact with RpfB (Hett et al., 2008; Hett et al. 2007), 
we cannot exclude a possible alternative activation mechanism during 
resuscitation from latency, which involves a conformational change of RipA on 
RpfB binding and a consequent unlock of RipA catalytic site. It should be 
noted, however, that RipA has a fundamental role in cell disconnection of 
actively growing bacteria. The collective dispensability of all five Rpfs in in vitro 
bacterial growth (Kana et al., 2008) makes an activation mechanism via 
proteolytic processing more plausible, at least during bacterial active growth. 
Consistent with this observation, activation via proteolytic maturation is the 
typical activation mechanism of cysteine proteases (Schroder and Tschopp, 
2010; Sripa et al., 2010). 
Our results provide a step forward in the molecular knowledge of the structural 
and functional properties of RipA in the PG degradation process. We 
demonstrate that this enzyme, vital to MTB, exists in a zymogenic form that 
needs to be activated. This evidences a regulation mechanism that is likely 
precious for a fundamental process like daughter cells separation. Finally, RipA 
is a secreted enzyme and easily accessible to drugs. 
I.4.4 Functional studies of RipA332-472 mutants 
To evaluate the impact of the other two putative catalytic residues His432 and 
Glu444 on the enzyme catalytic function, we measured the cell wall 
degradation ability of these mutants. Results show that these mutations have 
the same dramatic effect on the enzyme functionality observed for C383A 
mutant, with a complete loss of PG degradation activity (Figure 17). 
Intriguingly, despite the lower sequence conservation of Glu444, we observe 
this residue is fundamental for RipA catalysis. 
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Figure 17. Cell wall degrading activity of RipA332–472 and RipA332–472C383A, 
H432A, E444H mutants. 
Using CD spectroscopy, we checked conformational properties of all RipA332-472 
mutants, to exclude that the loss of activity was due to a decrease of the 
structural content of the enzyme upon mutation. Results show that all mutations 
do not affect RipA structural integrity, since CD spectra of mutants are 
superimposable to that of the un-mutated form (Figure 18). 
 
Figure 18. CD spectra of RipA332-472 mutants 
I.4.5 Crystal structures of RipA mutants 
To evaluate the effect of catalytic site mutation on the architecture of RipA 
catalytic site, we determined crystal structures of the two mutants, RipA263-
472C383A and RipA263-472H432A. Atomic resolution data were collected for both 
mutants (Table 3, pag.68). Differently, despite a complete conservation of 
protein secondary structure, we were unable to crystallize the E444H mutant, 
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likely due to a destructuration of the locking peptide induced by the +2 
charge difference. An analysis of electron density maps for RipA263-472C383A 
showed that the catalytic site of RipA remains virtually identical in the presence 
of the cysteine mutation. Indeed, the cavity formed by the lack of the Cys side 
chain is filled by a water molecule and the conformation of all residues of the 
catalytic side cleft is fully preserved (Figure 19A). Similarly, His mutation has 
marginal effect on RipA structure. In this case, the cavity formed by the lack of 
His side chain is filled by two water molecules (Figure 19B). 
 
 A                   B 
 
Figure 19. Comparison of the RipA crystal structure with mutants crystal 
structures.A) RipA catalytic site (indigo) vs RipA263-472C383A catalytic site (orange). B) RipA 
catalytic site (indigo) vs RipA263-472H432A (magenta). 
I.4.6 Modeling of substrate in RipA catalytic site 
Compared to NlpC/P60 containing enzymes, RipA structure is unique in 
possessing a domain (Aramini et al., 2008; Xu et al., 2009), the PB015164 
domain, that physically blocks the enzyme substrate binding cleft. The 
inaccessibility of catalytic residues to potential substrates in RipA structure 
makes experimental techniques to investigate enzyme-substrate interactions 
difficult to be carried out. On the other hand, no information on either the 
cleavage site on the substrate or the set of interactions between RipA binding 
cleft and its substrate is hitherto known. Therefore, we adopted modeling 
techniques to investigate interactions of the muropeptide GlcNAc-MurNAc-L-
Ala-γ-D-Glu-mesoDAP-D-Ala (Figure 20) with RipA catalytic domain. 
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Figure 20. Muropeptide GlcNAc-MurNAc-L-
Ala-γ-D-Glu-mesoDAP-D-Ala 
Molecular modeling, followed by energy 
minimization with GROMACS (Lindahl et al., 
2001), produced key information on the 
interaction mode of muropeptides in RipA 
binding cleft. Notably, the shape of RipA 
catalytic site cleft well accounts for the 
branched nature of PG. Consistently, the 
conformation of GlcNAc-MurNAc-L-Ala-γ-D-
Glu-mesoDAP-D-Ala is well locked by the catalytic site cleft. Both the carbonyl 
group and the side chain of DAP are tightly bound to the enzyme, through 
hydrogen bonding interactions with Gln431 and His432 (Figure 21). Also, the 
side chain of γ-D-Glu is h-bonded to the side chain of Ser384. Notably, the 
peptide group between γ-D-Glu and DAP forms several h-bonding interactions 
with the enzyme and directly contacts the catalytic residues Cys383 and 
His432. Beside h-bonding interaction with Gln431, the backbone N of DAP forms 
an h-bond with the nd1 atom of His432 side chain (Figure 21). Also, the 
carbonyl group of γ-D-Glu forms h-bonds with both the backbone nitrogen 
and the side chain of Cys383. 
Differently, Glu444 does not 
establish interactions with the 
substrate, but it hydrogen bonds 
His432. This feature confirms, as 
previously proposed that the role 
of Glu444 is to the properly orient 
the side chain of His432 (Ruggiero 
et al., 2010). By h-bonding the Ne2 
atom of His432, Glu444 locks His432 
in an orientation suitable to form 
an h-bond, through its Nd1 atom, 
with the backbone nitrogen of the 
DAP moiety. The observed 
conformation brings the peptide 
group linking γ-D-Glu to DAP in 
close vicinity to Cys383/His432 
C383 
H432 Q431 
S384 
H400 
Figure 21. Muropeptide in RipA 
binding cleft 
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catalytic dyad, a finding which suggests that RipA acts by cleaving the 
peptide bond between γ-D-Glu and DAP. The identified set of interactions is 
currently being used for the design of RipA inhibitors. 
I.5 CONCLUSION 
The process of daughter cell separation requires a delicate balance of cell wall 
hydrolases that cleave the septa connecting daughter cells. Cell-separating 
enzymes usually contain endopeptidase domains like CHAP or NLPC/P60 
domains, and/or Glucosaminidase domains (Layec et al., 2008; Layec et al., 
2009; Rossi et al., 2009).  RipA has a remarkable effect on the bacterial 
phenotype, since ripA depletion strains in M. smegmatis exhibit a decreasing 
growth and an abnormal phenotype, consisting in branching and chaining 
bacteria (Hett and Rubin, 2008). This enzyme is believed to cleave PG peptide 
crosslinks (Hett et al., 2008), similar to other cell separating endo-peptidases, 
like LytE, LytF, CwlS from B. subtilis (Fukushima et al., 2008; Margot et al., 1999; 
Margot et al., 1998) and Spr from E. coli (Aramini et al., 2008). 
RipA was cloned, expressed and purified in native conditions. Crystals were 
obtained using vapor diffusion techniques. The structure of RipA was solved by 
MAD using the anomalous signal from the Se atoms of labeled enzyme. 
Crystallographic studies of RipA have yielded new insights in the functional 
regulation of this enzyme. Indeed, the crystal structure clearly reveals a 
zymogenic nature of RipA, a finding which is confirmed by cell wall 
degradation assays (Ruggiero et al., 2010). Furthermore bacterial cell-wall 
degradation assays with mutated forms of RipA clearly identify the key 
catalytic triad of this enzyme. Finally, modeling of a PG fragment in the 
catalytic site of RipA has provided a key set of interactions, which will be 
exploited for the design of novel anti-tubercular therapeutics. 
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PARTII - Regulation of resuscitation from dormancy 
by STPK kinases and Penicillin Binding Proteins: the 
role of PASTA domains 
II.1 AIM OF THE STUDY 
Bacterial resuscitation from dormancy is a complex mechanism associated to 
stress and nutritional limitation and involves the recognition by bacteria that 
external conditions are optimal for growth. As such, this phenomenon requires 
a fine regulation which involves several molecular players active in 
muropeptide modeling and recognition.  
Among those, eukaryotic-type STPK PrkC have been shown to be essential for 
resuscitation of dormant B. subtilis (Shah and Dworkin, 2010; Shah et al., 2008). 
Generally, growing bacteria release muropeptides in the surrounding 
environment, due to cell wall PG remodeling associated to cell growth and 
division (Shah and Dworkin, 2010; Shah et al., 2008; Ruggiero et al., 2010). 
Therefore, the presence of muropeptides in the close environment of dormant 
spores is a clear signal that conditions are optimal for growth. Interestingly, B. 
subtilis spores germinate in response to m-DAP containing muropeptide, which 
constitutes B. subtilis cell wall (Shah et al., 2008). 
In order to understand the molecular mechanism allows PrkC to sense 
muropeptides in the bacterial milieu, we undertook a structural study of the 
extracellular region (EC) of PrkC from B. subtilis and S. aureus. Furthermore, by 
coupling crystallographic studies with bioinformatic analyses, calorimetric and 
spectroscopic studies we exploited the structural requirements necessary for 
recognition and binding and proved that m-DAP containing muropeptide 
physically binds to a specific PASTA domain of EC-PrkC from B. subtilis.  
Based on these results, we carried out structural studies of the PASTA domain of 
another protein from MTB, PonA2, which was shown to play an important role 
for the adaptation to dormancy of MTB (Patru et al., 2010). We hypothesized 
that the PASTA domain of PonA2 could act in a similar fashion as that of PrkC. 
Therefore, we applied NMR, calorimetric and computational methods to unveil 
structural and dynamic properties of PonA2 PASTA domain. 
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II.2 - BACKGROUND 
 
Eukaryotic-type STPK are expressed in many prokaryotes including a broad 
range of pathogens. Proteins of this class are known to regulate various cellular 
functions, such as developmental processes, secondary metabolism, stress 
response, biofilm formation, antibiotic resistance, virulence, cell wall biogenesis, 
cell division, and central metabolism (Madec et al., 2002; Fiuza et al., 2008). 
The first reported eukaryotic-type STPK, Pkn1 from Myxococcus xanthus, was 
found to be required for normal bacterial development (Mu˜noz-Dorado et al., 
1991). The advance of genome sequencing has prompted the identification of 
similar kinases in many bacteria. 
Previous studies have found that the eukaryotic-type STPK PrkC from Bacillus 
subtilis is also involved in bacterial exit from dormancy (Shah, 2008; Shah and 
Dworkin, 2010). Under conditions of nutritional limitation, B. subtilis produces 
spores which are resistant to harsh environmental conditions and can survive in 
a dormant state for years (Shah, 2008; Kana et al., 2010; Keep et al., 2006). The 
process of resuscitation is called, in these sporulating bacteria, germination 
(Shah, 2008; Shah and Dworkin, 2010).Generally, growing bacteria release 
muropeptides into the surrounding environment, owing to cell wall PG 
remodeling associated with cell growth and division (Hett et al., 2008; Ruggiero 
et al., 2010). Therefore the presence of muropeptides in the close environment 
of dormant spores is a clear signal that the conditions are optimal for growth. 
Consistently, Shah et al. (2008) reported that m-DAP-containing muropeptides 
are powerful germinants of B. subtilis spores. Notably, other authors have 
proposed independently the idea that the activating ligand of PrkC could be 
a component or a degradation product of the cell wall PG (Absalon et al., 
2009). These authors also showed that, once activated, PrkC is able to 
phosphorylate the small-ribosome-associated GTPase CpgA, the translation 
factor EF-Tu (elongation factor thermo-unstable) and a component of the 
bacterial stressosome, denoted YezB (Absalon et al., 2009). On the other hand, 
the possible involvement of EF-G (elongation factor G) as a substrate of PrkC is 
controversial (Absalon et al., 2009; Shah et al., 2008; Gaidenko et al., 2002). A 
close homologue of PrkC exists in Staphylococcus aureus, a significant human 
pathogen that causes a number of infections ranging from skin infections to 
toxic shock syndrome, osteomyelitis and myocarditis (McGahee et al., 2000; 
Ohlsen et al., 2010). PrkC from S. aureus is predicted to be a membrane 
protein, similar to its homologue from B. subtilis. The two kinases present the 
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same domain organizations, with an intracellular serine/threonine kinase 
domain, a transmembrane region and an extracellular portion that contains 
three domains known as Penicillin binding Associated and Serine/Threonine 
kinase-Associated (PASTA) domains. According to Shah et al. (2008), B. subtilis 
spores germinate in response to m-DAP-containing muropeptide, which 
constitutes the B. subtilis cell wall, but not in response to L-lysine-containing 
muropeptide. Moreover, when the PrkC from B. subtilis is replaced by PrkC from 
S. aureus, which is characterized by L-lysine-containing cell walls, germination is 
observed both in response to m-DAP and L-lysine-containing muropeptide. This 
finding has shown that the source of PrkC determines the bacterial ability to 
respond to muropeptides and has suggested that PrkC extracellular domains 
exhibit specificity of muropeptide binding (Shah et al. 2008). 
PASTA domains also exist in PBP (Patru et al., 2010). The crystal structure of the 
PBP2x from Streptococcus pneumoniae, which contains two C-terminal PASTA 
domains, was solved in complex with cefuroxime, a β-lactam antibiotic 
mimicking the unlinked PG (Gordon et al., 2000; Dessen et al., 2001). 
Interestingly, the PBP PonA2 from MTB contains one PASTA domain and has 
been associated with regulation of bacterial resuscitation from dormancy. 
These findings suggest that PASTA domains can sense muropeptides. Despite 
these hypotheses, structural results are still needed to help the understanding 
of the function of extracellular PASTA domains. 
 
II.3 - EXPERIMENTAL PROCEDURES 
II.3.1 Expression and purification of Extra Cellular region of PrkC from 
S. aureus and B. subtilis 
The plasmidic constructs corresponding to the EC region of S. aureus PrkC (EC-
PrkC S.a, residues  378- 664) and of B. subtilis (EC-PrkC B.s, residues 356-648) 
have been prepared as previously described by Shah et al. (2008). The 
overexpression of EC-PrkC S.a and  of EC-PrkC B.s , containing an N-terminal 
histidine tag (His6) were carried using E. coli DH5a cells (Invitrogen). Briefly, an 
overnight starting culture of 100 mL were prepared to grow 1 L of LB containing 
100 μg/mL ampicillin. Induction was performed at OD 600=0.6 with 0.02% (w/v) 
L-arabinose and harvested after four hours. The proteins were isolated by 
sonicating resuspended cells in a binding buffer (10 mM imidazole, 200 mM 
NaCl, 20 mM TrisHCl, 5%(v/v) glycerol pH 8.0) containing a protease inhibitor 
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cocktail (Roche Diagnostic). The lysate were cleared by centrifugation at 
18,000 rpm, and the supernatants loaded on a 5-mL Ni2+-NTA column 
(GEHelthcare), equilibrated with binding buffer. After washing with 10 volumes 
of binding buffer, a linear gradient of imidazole (10-300 mM) was applied to 
elute the proteins. Fractions containing the proteins were pooled and loaded 
on a gel filtration column (Superdex 200, GeHelthcare), equilibrated in 150 mM 
NaCl, 20 mM TrisHCl buffer at pH 8.0 and 5% (v/v) glycerol, for a further 
purification step. The proteins eluted in a single peak and were homogeneous, 
as judged by SDS–PAGE analysis. All the purification steps were carried out at 
4°C. The proteins were concentrated using a centrifugal filter device (Millipore), 
and the concentration were determined by Bradford protein assay (Biorad). 
Fresh concentrated proteins at 10 mgxmL-1, were used for crystallization 
experiments. 
II.3.2 Cloning, expression and purification of 15N/13C labeled PONA2 
PASTA domain from M. tuberculosis 
The region encoding amino acids G700 to I764 of PONA2 was amplified by PCR 
using genomic DNA of MTB as template (H37Rv strain, Figure 4A) and the 
following oligonucleotides as primers (ponA2 forward: 
CATGCCATGGGCTCACGGGTACCAAGC; ponA2 reverse: 
CCCAAGCTTATCAGATGCCGTTGCTGATCTGG). NcoI/HindIII-digested 
fragments were cloned into the pETM-11 (Figure 4B) with N-Terminal Histag 6xHis 
tag for metal-affinity purification. The resulting positive plasmid was used to 
transform E. coli Star BL21(DE3) competent cells. Transformed cells were 
cultured overnight in LB broth with 50 µg ml−1 kanamycin at 37°C . For the 
production of isotope labeled sample (15N/13C ) the culture was seeded in 
1:100 volume ratio either in 1 L of minimal media (M9) containing (422mM of 
Na2HPO4, 220mM of KH2PO4, 85,5 mM NaCl, 186,7 mM of 15N ammonium 
chloride, 1mM MgSO4 , 0.2mM CaCl2, 1 mL of Thiamine 40 mgxml-1 and 0.3% 
final of 13C-glucose. Culture was grown at 37° C in a shacking incubator, 
induced with 0.7 mM IPTG, and further grown at 22°C for 18 hours for protein 
production. E. coli cells were harvested by centrifugation at 6000 rpm for 20 
min, and the bacterial pellet re-suspended in a buffer containing 300 mM 
NaCl, 50mM Tris-HCl, 10mM m imidazole, 5% (v/v) glycerol and complete 
protease inhibitor cocktail (Roche) pH 8 and lysed by sonication on ice to 
release recombinant protein. The cell lysate was centrifuged at 16500 rpm at 
4°C for 30 min and the surnatant loaded on Ni2+-derivatized HisTrap columns 
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(GE Healthcare). After washing with 10 volumes of binding buffer, a linear 
gradient of imidazole (5-300 mM) was applied to elute the protein. Eluted 
protein was dialyzed against buffer without imidazole containing 150 mM NaCl, 
50 mM Tris-HCl, 5% glycerol pH 8.0 at 4°C for 4 hours and after was digested 
with TEV pretease to remove the 6xHis tag. The protein was further purified by a 
second Ni2+ affinity chromatography and by a gel filtration on Superdex75 (GE 
Healthcare) with a buffer containing 150mM NaCl, 50mM Tris-HCl, pH 8. The 
protein, which eluted in a single peak, was concentrated using a centrifugal 
filter device (Millipore) with a cut-off of 3KDa, and the concentration was 
determined using the Pierce BCA Protein Assay Kit. The fresh concentrated 
protein (1mM) was dialyzed against the NMR buffer containing 30mM sodium 
phosphate buffer pH 6.5. 15N/13C labeled protein was prepared with 5% of 
sodium azide and 10% of deuterated water for NMR experiments. 
II.3.3 Circular dichroism experiments 
CD spectra were recorded with a Jasco J-810 spectropolarimeter equipped 
with a Peltier temperature control system (Model PTC-423-S). Molar ellipticity 
per mean residue, [] in deg cm2·dmol-1, was calculated from the equation: [] 
= []obs·mrw·(10·l·C)-1, where []obs is the ellipticity measured in degrees, mrw 
is the mean residue molecular mass (111.17 Da for EC-PrkC S.a, 110.11 Da for 
EC-PrkC B.s and 102 Da for PonA2-PASTA, respectively), C is the protein 
concentration in g·L-1 and l is the optical path length of the cell in cm. Far-UV 
measurements (190-260 nm) were carried out at 20 °C using a 0.1 cm optical 
path length cell and protein concentration of 0.2 mgxmL-1. 
II.3.4 Crystallization experiments 
Crystallization trials were performed at 293 K using the hanging-drop vapor-
diffusion method. Preliminary crystallization conditions were set up using a 
robot station for high throughput crystallization screening (Hamilton STARlet 
NanoJet 8+1) and commercially available sparse-matrix kits (Crystal Screen kits 
I and II, Hampton Research, Index).  
The initial screenings revealed several promising conditions for crystallization of 
EC-PrkC S.a. Optimization of the crystallization conditions was performed 
manually both using the vapor-diffusion and the macroseeding technique. 
After optimization of the crystallization conditions, only tiny needles could be 
obtained. Best crystals of EC-PrkC S.a were obtained using the macro-seeding 
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technique. Needles were partially dissolved in their mother liquor and 
transferred to solutions containing mixtures, at 1:1 ratio, of 10 mgxmL-1 EC-PrkC 
S.a and dilutions of commercially available solutions (Hampton Research). 
LuCl3-derivative crystals were prepared by soaking a native crystal in a solution 
containing 1–3 mM EuCl3, 25% (w/v) MPEG 2000 [methoxypoly(ethylene glycol) 
2000 kDa], 160 mM (NH4)2SO4 and 60 mM sodium acetate trihydrate buffer for 
3 hours at pH 4.6. 
II.3.5 Data collection and processing of EC-PrkC from S. aureus 
A MAD experiment was carried out on a crystal derivatized with 2 mM LuCl3 at 
the X12 synchrotron beamline, DORIS storage ring, DESY (Deutsches Elektronen 
Synchrotron; Hamburg, Germany), at 100 K (Table 4, pag 69). Cryoprotection 
of the crystals was achieved by a fast soaking in a solution containing glycerol 
to a final concentration of 10% (v/v). These data, extending to 3.0 Å (1Å=0.1 
nm) resolution, allowed us to build a part of the molecule. Derivatization by 
overnight soaking in a solution containing 2 mM EuCl3 provided higher 
resolution X-ray data, at 2.15 Å (Table 3, pag. 68). Data collection was 
performed in-house at 100 K using a Rigaku Micromax 007 HF generator 
producing Cu Kα radiation and equipped with a Saturn944 CCD (charge-
coupled device) detector. The datasets were scaled and merged using the 
HKL2000 program package (Otwinowski et al., 1997)(Table 3, pag. 68). 
II.3.6 Structure determination of EC-PrkC from S. aureus 
Phasing was achieved using in-house SAD (Single-wavelength Anomalous 
Diffraction) data, collected on a crystal soaked overnight in a solution 
containing 2 mM EuCl3. These data provided structural factor phases to 2.2Å 
resolution. Both SHELXD (Sheldrick  et al., 2008) and SOLVE (Terwilliger, 2004) 
identified five Eu3+ ions. Phases, improved by phase extension and density 
modification by RESOLVE (Terwilliger, 2004) and wARP (Langer e al., 2008), 
allowed us to trace nearly the entire molecule structure. Crystallographic 
refinement was carried out against 95% of the measured data using the CCP4 
program suite (Potterton et al., 2003) . The remaining 5% of the observed data, 
which was randomly selected, was used in Rfree calculations to monitor the 
progress of refinement. Structures were validated using the program 
PROCHECK (Laskowski et al., 1996). 
II.3.7 Homology modeling of EC-PrkC from B.subtilis 
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The three-dimensional structure of EC-PrkC was modeled by comparative 
protein modeling methods using the MODELLER workspace. The model was 
built using the 2.2 Å resolution structure of the EC region of PrkC from S. aureus 
(Protein Data Bank (PDB) entry 3py9) as a template. The degree of sequence 
identity between the template (residues 377-660) and EC-PrkC (residues 361-
643) is 28.7%, which enabled a preliminary model to be generated. This model 
was energetically minimized using GROMACS (Lindahl E. et al., 2001). 
II.3.8 Sequence alignments and mutants design 
For sequence conservativeness studies, residue conservation scores were 
obtained using the program CONSURF. Homologous sequences were 
collected using PSI-BLAST heuristic algorithm with default parameters (Kaushik 
S., et al., 2013).  The search was carried out in the full UNI-PROT knowledgebase 
(SWISS-PROT + TrEMBL) database, using an E-value cutoff of 0.001. The program 
MUSCLE was used to align the homologues extracted from the PSI-BLAST output 
file. 
For the identification of the DAP interaction site on the protein, a statistical 
survey was carried out by searching all structures containing DAP in the PDB. 
This analysis was conducted using the Application Programming Interface 
implemented in the PDB server. 
II.3.9 EC-PrkC from B. subtilis mutants production 
R500E and R500A mutations were generated by site-directed mutagenesis of 
wild-type recombinant plasmid pBAD24/EC-PrkC using the Stratagene 
QuikChange kit. Mutagenic primers for R500E were 5'-
CCGAAGACATTACGCTTGAAGACTTGAAAACCTACAG-3' and 5'-CTGTAGGT 
TTTCAAGTCTTCAAGCGTAATGTCTTCGG-3'. Primers for R500A were 5'-
CCGAAGACATTACGCTTGCAGACTTGAAAACCTACAG-3' and 5'-
CTGTAGGTTTTCAAGTCTGCAAGCGTAATGTCTTCGG-3'. Introduction of the 
expected mutations was confirmed by DNA sequencing. Expression and 
purification of the two mutants were performed using the same conditions 
used for the wild-type form. 
II.3.10 Isotermal titration calorimetry experiments 
The interactions of EC-PrkC from B. subtilis with natural muropeptides from 
Bacillus subtilis were investigated at 298K by Isothermal Titration Calorimetry 
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(ITC) using a MicroCal ITC200 calorimeter (GEHelthcare Milan) calibrated with  
standard electrical pulses. All solutions were degassed by stirring under 
vacuum before use. 18 consecutive injections of 2 µL aliquots of a 20 mM 
solution of muropeptides (the molecular weight was calculated based on the 
3:1 molar ratio between muropeptides B and A, Figure 27) were added to the 
calorimeter cell (0.280 mL) containing 0.05 mM of EC-PrkC at intervals of 150. 
Similarly, interactions of ponA2-PASTA with synthetic mur-TriDAP (InvivoGen) 
were checked using a protein concentration of 0.15 mM, which were titrated 
with 15 mM mur-TriDAP. 
In all experiments, proteins and titrants were prepared in the same buffer (PBS 
1X) to minimize the contribution of the dilution heat. In order to ensure proper 
mixing after each injection, a constant stirring speed of 1000 rpm was 
maintained during the experiments. Data were analyzed using a ‘one set of 
sites’ binding model. 
II.3.11 NMR experiments of ponA2-PASTA domain from M. 
tuberculosis 
All NMR experiments were recorded at 298 K on Inova 600 MHz spectrometer 
(1H-15N experiments), equipped with a cryogenic probe optimized for 1H 
detection, or Varian Inova 500 MHz (1H-13C-15N triple resonance experiments), 
using the standard pulse sequences. NMR samples consisted of approximately 
1.4-1.8 mM unlabeled or uniformly 15N or 15N-13C doubly labeled protein 
dissolved in 30 mM sodium phosphate (pH 6.4), 0.02% sodium azide and 10% 
2H2O. 1H chemical shifts were directly referenced to the methyl resonance of 
TSP, while 13C and 15N chemical shifts were referenced indirectly to the 
absolute 13C/1H or 15N/1H frequency ratios. 
The 1H-15N- Heteronuclear Single Quantum Coherence (HSQC) spectra were 
recorded with a number of complex points (cp) and acquisition times equal to 
128 cp and 64 ms for 15N (F1 dimension) and 1024 cp and 146 ms for 1H (F2 
dimension). The assignment of 1H and 15N resonances was achieved using a 
suite of heteronuclear 2D and 3D spectra: 1H-15N-HSQC, 3D [1H, 15NH]-TOCSY-
HSQC and, 3D [1H, 15NH]-NOESY-HSQC. The assignment was extended to 13C 
resonances and globally assessed by analyzing HCCH-TOCSY and triple 
resonance (HNCO, HNCACN, CBCA(CO)NH) experiments. NMR experiments 
were processed using the software Varian (VNMR 6.1B). The program CARA 
was used to analyze and assign the spectra. The assignments of the aliphatic 
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side-chain 1H resonances remain in some cases ambiguous due to cross peaks 
overlapping. Globally, the NMR analysis of the double label-ed (15N-13C) 
PonA2-PASTA allowed us to confidently assign 98 % of the resonances. 
The structure calculation was performed by program CYANA 2.1 starting from 
150 random conformers. 3D structure of PonA2-PASTA domain was determined 
based on 465 experimental NOE constraints and 87 constraints on Ф and φ 
torsion angles as obtained on the basis of backbone (HN, 15N, 13Cα, 13C’, 13Cβ) 
chemical shifts using TALOS+. The 40 conformers with the lowest final CYANA 
target function values (TF average value= 1.68 ± 0.19 Å2) showed an average 
backbone RMSD = 0.62 ± 0.31 Å and an average heavy atom 1.02 ± 0.29 Å. 
Validation procedure using PROCHECK-NMR (Laskowskiet al., 1993) program 
demonstrated that the final family of 3D structures is in agreement with the 
distance restraints. The molecular graphics program MOLMOL (Koradi et al., 
1996). was employed to perform the structural statistics analysis. 
II.3.12 Relaxation measurements 
Backbone 15N relaxation parameters (R1, R2 and hetero-nuclear NOE) were 
obtained for 15N-labeled PASTA sample at the concentration of 200 µM by NMR 
experiments recorded at 298 K and 600 MHz. Seven relaxation delays were 
used both for R1 (0.01, 0.05, 0.1, 0.3, 0.6, 0.8, 1s ) and R2 (0.01, 0.03, 0.07, 0.09, 
0.13, 0.15, 0.19 s) measurements. 15N-{1H} hetero-nuclear steady state NOEs 
were measured with recycling time of 5 s and 3 s of proton saturation period. 
The rotational correlation time was determined by using the average R2/R1 
values. 
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II.4 RESUSTS 
II.4.1 Structural studies of EC-PrkC from S. aureus 
PrkC from S.a is a 664-residue-long multidomain protein. Using sequence 
analysis tools, the PrkC sequence is predicted to embed a serine/threonine 
kinase domain (residues 1–270), a region of unknown structure and function 
(residues 271–377) that includes a transmembrane helix (residues 349–373) and 
an extracellular region, denoted EC-PrkC (residues 378–664) (Figure 22).  
 
Figure 22. Domain prediction of PrkC, according to the Pfam database 
We determined the crystal structure of EC-PrkC S.a, which is predicted to 
contain three successive PASTA domains (Figure 22). We overexpressed this 
fragment of PkrC in E. coli and obtained a soluble form that was amenable for 
crystallization. Since a sole methionine residue is present in the sequence of EC-
PrkC, we tackled structure factor phasing by preparing derivatives of EC-PrkC 
crystals with several heavy metals. The best results were obtained with 
lanthanides. Indeed, MAD data collection using a LuCl3-derivatized crystal was 
performed at DESY. Diffraction data, at 2.9Å resolution, allowed us to trace a 
significant part of the molecule. Higher diffraction data (2.2Å resolution) were 
collected in-house on a EuCl3-derivatized crystal. Using the SAD method, these 
data produced a readily interpretable electron density throughout the entire 
structure. The final model contained 285 residues, five Eu3+ ions and 125 water 
molecules.  
Data collection, refinement and model statistics are summarized in the Table 4 
(pag. 69). 
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II.4.2 EC-PrkC from S. aureus has the 
shape of a golf club 
The crystal structure of EC-PrkC revealed 
that it consists of four consecutive 
domains. The four domains are arranged 
sequentially in a golf-club shape, such 
that only neighbouring domains interact 
with each other (Figure 23). Three of the 
four domains are, as predicted, PASTA 
domains (Figure 22). The structure shows 
that the three PASTA domains display a 
linear and regular organization. Indeed, 
each domain exhibits a two-fold 
symmetry with respect to its neighbouring 
domains (Figure 23). In this organization, 
the sole α-helix of each domain is 
alternatively located on the two sides of 
the golf club. Interestingly, the structure 
reveals the existence of a fourth domain, 
at the C-terminal end of the molecule, 
not predicted by searches in the PFAM 
database (Finn et al., 2008). Furthermore, 
sequence analyses against the PDB do 
not identify any significant homologue for 
this domain.  
Figure 23. Ribbon representation of EC-PrkC S.a. Helices and β-strands are 
shown in orange and blue respectively. 
II.4.3 Features of PASTA domains 
The present study provides the highest-resolution study of PASTA domains, 
which are arranged in βαββββ motifs (Figure 23). Despite moderate sequence 
identity between EC-PrkC PASTA domains (from 21 to 27%), the structures of 
these domains are well conserved. PASTA domains are also constituents of the 
PBP2x protein from S. pneumoniae (PDB code 1QME) (Gordon et al., 2000). The 
crystal structure of PBP2x shows that its two PASTA domains form a compact 
structure with a pronounced interdomain bending (Figure 24A). In this 
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arrangement, each PASTA domain is involved in interactions with both the 
other PASTA domain and with the dimerization and transpeptidase domains of 
PBP2x (Gordon et al., 2000). In contrast, in the structure of EC-PrkC, the three 
PASTA domains are arranged linearly, with a limited number of interdomain 
interactions. This finding suggests a high flexibility of the EC-PrkC. The structural 
comparison of PrkC PASTA domains with those of PBP2x shows a significant 
conservation of the PASTA fold, despite the low sequence identities, ranging 
from 5 to 28%, between domains. All secondary-structure elements are 
conserved, although β-strands β4 and β5 do not appear in lower resolution 
PBP2x structures (Figure 24B) (Pares et al.,1996). 
                             A)                                                                        B) 
 
Figure24. A) Superposition of the PASTA domain 1 of PBP2x (PBP2x-1, orange) 
with the PASTA domain 2 of PrkC (purple). B) Top view of PBP2x structure. The 
ribbon and surface representations of PASTA domains are coloured orange, 
whereas representations of the rest of the molecule are shown in green. 
Superpositon of EC-PrkC structure with the Small Angle X-ray Scattering (SAXS) 
structure of the extracellular portion of its homologue PKnB from MTB (four 
PASTA domains) shows that, similar to PrkC, the organization of PASTA domains 
in the PknB  is nearly linear (Figure 25B) (Gordon et al., 2000; Barthe et al., 2010). 
However, the overall Root Mean Square Deviation (RMSD) calculated on Cα 
atoms after superposition of the three PASTA domains of EC-PrkC from S.a with 
those of PknB is as high as 9.5Å (after superposition with PknB PASTA domains 2, 
3 and 4) and 14.4Å (after superposition with PknB PASTA domains 1, 2 and 3). 
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This is mainly due to different arrangements of PASTA domains in PrkC and PknB 
(Figure 25A, B). Indeed, when single PASTA domains of EC-PrkC and PknB are 
superposed, a strong conservation of the domain fold is observed, even in 
cases when sequence identities are as low as 2–5%. On the basis of the 
observation that the two PASTA domains of PBP2x interact with each other 
(Figure 25A) (Gordon et al., 2000), the authors proposed that extracellular 
regions of PknB dimerize to activate the kinase, since only dimerization would 
bring two PASTA domains in close contact (Barthe et al., 2010). However, it 
should be noted that the two PASTA domains of PBP2x are oriented in opposite 
directions (Figure 25B). Therefore similar interactions would produce PrkC 
dimers that would not allow the catalytic domains to interact. 
 
Figure 25. Comparison of EC-PrkC S.a with PknB from MTB. A) Ribbon representation 
of the X-ray structure of EC-PrkC. B) Ribbon representation of PASTA domains arrangement in 
PknB, as derived by SAXS studies; PDB code 1KUI. C) Superposition of PknB PASTA domain 1 
(light grey) with PrkC PASTA domain 2 (dark grey). 
II.4.4 Features of the Immunoglobulin (IG)-like domain 
The crystal structure shows of EC-PrkC S.a contains a C-terminal domain which 
was not predicted by searches in the PFAM database (Figure 22). This latter 
domain (residues 577–664), exhibits an all-β structure, which contains six β-
strands arranged in a β-sandwich. Sequence alignment analyses do not 
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identify any structure in the PDB with significant sequence identity. However, a 
DALI (Holm and Sander, 1995) search of the PDB reveals that PrkC C-terminal 
domain structurally resembles a set of IG domains. The canonical structure of 
IG domains is formed by a three-stranded and a four-stranded β-sheet packed 
in β-sandwich arrangement (Bork et al., 1994). Like canonical IG domains, PrkC-
IG domain (PrkC-IG) presents a hydrophobic core formed by both β-sheets, 
whereas residues pointing to the solvent are mainly hydrophilic; this results in 
alternating polar/non-polar sequence patterns of the β-strands. The topology 
of PrkC-IG can be classified as belonging to the s-type IG domains (Bork et al., 
1994). However, superposition of PrkC-IG to those identified with DALI (Table 5) 
shows that this domain lacks the N-terminal strand (β-strand β* of the canonical 
IG domain; Figure 26).  
 
The sole identified protein that shares a similar feature is a type III domain of 
human fibronectin (PDB code 2H41; Table 5). In EC-PrkC, the N-terminal lacking 
strand of PrkC-IG forms the linker with the PASTA3 domain (Figure 23). Different 
from typical IG folds, where hydrophobic residues in the β* strand pack against 
the hydrophobic core, the PrkC linker is highly hydrophilic. The volume 
occupied by hydrophobic residues of the β* strand in canonical IG domains is 
filled by bulky hydrophilic residues of β-strands β1 and β6 in EC-PrkC S.a (results 
not shown). It is worth noting that IG domains similar to PrkC-IG are usually 
involved in cell–cell interactions and cell signalling (Lemmon and Schlessinger, 
2010). Their adhesive properties are exploited both by bacterial (Bowden et al., 
2008; Ganesh et al., 2008) and eukaryotic cells (Carafoli et al., 2008) and are 
typically due to the exposure of an anomalously large number of backbone β-
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strand hydrogenbond donors and acceptors (Richardson et al., 2002). This is 
particularly true when IG folds are not complete and lack one β-strand (as in 
PrkC-IG), since this feature leads in extreme cases to IG polymerization (Kline et 
al., 2010; Vitagliano et al., 2007). These properties of PrkC-IG S.a suggest that 
this domain may also play a role in peptidoglycan binding, in a fashion similar 
to the E. coli adhesin PapG with host glycolipids (Dodson et al., 2001; Imberty et 
al., 2005). Consistently, we noted that PrkC from B. subtilis, which shares similar 
properties in inducing bacterial sporulation, also contains a similar domain at its 
C-terminus. 
 
Figure 26. Schematic diagram of canonical IG domain topology. The grey strand 
in the topology sketch (strand β*) is lacking in PrkC-IG. 
II.4.5 Binding studies of PrkC from B. subtilis to muropeptides 
B. subtilis spores germinate in response to DAP-type muropeptides but not in 
response to L-Lys-type muropeptides. This finding suggests that PrkC 
extracellular domains exhibit specificity of muropeptide sensing. However, 
whether muropeptides are able to bind the protein physically and how the 
extracellular region is able to distinguish the two types of muropeptides was 
hitherto unknown. 
To explore the structural requirements necessary for recognition and binding of 
muropeptides to PrkC from B. subtilis, we expressed and purified the extra-
cellular portion of the protein and performed binding studies with m-DAP 
containing muropeptide blend (GlcNAcMurNAcAla2GluDAP, 
GlcNAc2MurNAc2Ala4Glu2DAP2: Figure 27), purified in the group of Prof. 
Molinaro from the University of Naples. 
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                                             A                                           B 
 
 
Figure 27. Chemical structures of typical constituents of a muropeptide blend, 
composed of monomers A) and dimers B). 
 
Using ITC technique we proved that muropeptides are able to bind EC-PrkC 
from B. subtilis and measured their binding affinity to the protein. Using the 
typical blend of muropeptides released during cell wall remodeling (Figure 27), 
we observed a low-millimolar protein−ligand affinity, with Kd = 1.2 mM (Ka = 
801.0 ± 33.3 M−1, ΔH = −14.7 ± 0.4 kcal · mol−1) (Figure 28). 
 
Figure 28. Muropeptide binding with EC-PrkC. Raw data for the titration of 50 µM 
protein with 20 mM muropeptide blend (muropeptides B and A in 3:1 ratio) at 25°C. Integrated 
heats of binding obtained from the raw data, after subtracting the heat of dilution, are shown 
in the inset. The red line represents the best curve fit to the experimental data, using the ‘one 
set of sites’ model from MicroCal Origin Software. 
 
Saturation Transfer NMR data obtained in the group of Prof. Molinaro from the 
University of Naples, revealed the binding epitope of the muropeptide, by 
measuring relative STD effects from the STD amplification factors. These studies 
showed that strongest STD NMR signals involve the DAP residue whereas low-
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intensity STD signals were recorded for the carbohydrate moieties. The key 
involvement of the DAP residue in protein recognition well agrees with the 
previous finding that only muropeptides containing DAP in their peptide stem 
resuscitate B. subtilis, whereas L-Lys-type muropeptides do not (Shah et al., 
2008). The NMR binding data also showed that EC-PrkC B.s is unable to bind 
Lys-type peptides.  
II.4.6 Bioinformatic studies: Statistical survey and homology 
modeling 
Prompted by the observed binding of muropeptides to EC-PrkC B.s, we 
focused on the identification of their interaction site on the protein surface. We 
attempted crystallization of EC-PrkC B.s with no success. Therefore, we 
determined the three-dimensional model of EC-PrkC from B.subtilis using 
homology modeling (Figure 29).  Modeling was carried out using the software 
MODELLER and the structure of EC-PrkC from S.aureus as a template (28.7% 
sequence identity).  
Analysis of sequence conservation on the model surface did not suggest any 
obvious conserved patch of residues which could play a role in muropeptide 
binding. Therefore, the key role of DAP in protein recognition revealed by STD 
NMR studies prompted us to perform a statistical survey PDB to identify the 
structural determinants responsible for DAP binding to proteins. Notably, in all 
structures of protein complexes with DAP, the carboxylate end of DAP forms a 
salt bridge with an arginine side chain (Figure 29). This finding suggested us that 
muropeptide binding occurs mainly through the interaction of DAP with an 
arginine residue of EC-PrkC from B. subtilis.  
The homology model of EC-PrkC from B. subtilis shows the location of the two 
arginine residues in the protein structure (Figure 29). Arg614 is located in the IG-
like domain and is involved in a salt bridge with Glu604 (Figure 29A). On the 
other hand, Arg500 in located the PASTA3 domain and is fully solvent-exposed 
(Figure 29B). These considerations led us to hypothesize that Arg500 is involved 
in muropeptide binding in a fashion similar to those observed in the PDB (Figure 
30). To corroborate this hypothesis, we produced mutants of EC-PrkC B.s in 
which Arg500 was changed to alanine (R500A) and to glutamic acid (R500E), 
two residues which we predicted to be more disruptive of the Arg−DAP 
interaction.  
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Figure 29. Structure of EC-PrkC from B. subtilis derived by homology modeling. 
The two insets show enlargements of A) the salt bridge between Arg614 and Glu604 in the IG-
like domain and B) the location of Arg500 in PASTA3. 
 
STD experiments unequivocally showed that neither R500E nor R500A are able 
to bind muropeptides, as no STD signals were observed in either case (data not 
shown). To exclude that the inability of mutants to bind muropeptides was due 
to alterations of their structure, we carried out CD spectroscopy studies. These 
studies showed CD spectra of mutants were superimposable to that of the 
unmutated structure and excluded the possibility of defects in protein folding 
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induced by the mutations (Figure 31). The inability of the R500E and R500A 
mutants to bind muropeptides shows that Arg500 is the primary site of 
interaction with muropeptides. Therefore, we were able to map the site of 
interaction both on the muropeptides and on EC-PrkC B.s and could conclude 
that PrkC senses muropeptides through interactions of the negatively charged 
DAP side chain of the muropeptide with the side chain of Arg500. 
 
Figure 30. Interaction of DAP with protein structures available in the Protein Data 
Bank. The four panels represent the binding of DAP to (a,b) Corynebacterium glutamicum 
diaminopimelate dehydrogenase (PDB codes 2DAP and 1F06, respectively), (c) UDP-N-
acetylmuramoyl-L-alanyl-D-glutamate: meso-diaminopimelate ligase from Escherichia coli 
(PDB code 1E8C), (d) Drosophila peptidoglycan recognition protein (PGRP)-LE (PDB code 
2CB3). 
 
Figure 31. CD spectra of R500A (black) and R500E (red) mutants of EC-PrkC 
from B.subtilis compared to the CD spectrum of EC-PrkC not mutated (green). 
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II.4.7 Structural features of the PASTA domain of PonA2 from M. 
tuberculosis 
We coupled CD and NMR spectroscopy studies with computational 
approaches to gather insights into the structure and binding properties of the 
PASTA domain of the PBP PonA2 from M. tuberculosis.  
The PASTA domain (PonA2-PASTA, residues 700-764) of PonA2 was produced as 
isotope labeled (15N/13C ) for NMR experiments. Prior to these studies, PonA2-
PASTA fold and stability were evaluated using UV circular dichroism (CD) 
spectroscopy (Figure 32). CD spectra are characterised by two minima at 208 
nm and 222 nm and witness a good degree of structural integrity of the 
domain (Figure 32). The analysis of thermal denaturation curves evidences that 
PonA2-PASTA is a stable module with a melting temperature (Tm) of 42°C 
(Figure 32) and a fully reversible denaturation process (Figure 32). 
 
 
 
 
 
 
Figure 32. CD studies of ponA2-PASTA. Left) Superposition of CD spectra at 20°C and 
after refolding from 70°C to 20°C. Right) Thermal denaturation curve. A red arrow locates the 
melting T. 
The 1H–15N heteronuclear single quantum coherence (HSQC) spectrum of 15N–
labeled PonA2-PASTA domain shows a good dispersion of signals indicative of 
a well-folded structure (Figure 33). The 3D model (Figure 34), calculated by 
CYANA program, shows a global topology consisting of a α-helical segment 
approaching a three stranded β-sheet. The N-terminal helix, which involves 
about 10 residues, from Val12 to Ala22, is well defined by a dense set of NOE 
effects (RMSD= 0.05 ± 0.02 Å). Extended conformation is found in the traits 
Ala27-Ser32 (β1), Gly40-Thr45 (β2) and, Val57-Ser62 (β3). The RMSD values 
measured on backbone atoms (20 structures) of β1, β2 and β3 strands are all < 
0.11 ± 0.06 Å. The inter-strands NOEs (particularly dense between the anti-
parallel β2 and β3) used as constraints in the structure calculation gave back 
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the β1-β3-β2 expected arrangement for PASTA PonA2-PASTA sheet. The helix 
orientation is defined by NOE contacts between side chains from pre-helix 
residues (Ala8-Gly9) and β2 ones (Val42-Val43). Phe24 and Tyr39, the only two 
aromatic residues own by the sequence, are both localized in loop regions. 
Phe24 side chain, in particular, participates to the hydrophobic core. The 
numerous unambiguous long range NOEs involving Phe24 aromatic protons 
and Val4, Leu19, Gly39 and Val57 side chains define the structure of the 
hydrophobic core. N- and C-terminus residues Ser2 and Asn63 participate to 
the long range NOEs network with loop nuclei. The backbone flexibility was 
tested by analyzing relaxation measurements performed on 15N backbone 
nuclei. The values of R2/R1 relaxation rate ratios as well as 15N-{1H} hetero-
nuclear NOEs are quite uniform along the sequence except for the more 
flexible very N-terminal residues. Globally, the domain appears compact. 
Relevant structural parameters and statistics are given in Table 6 (pag. 70). 
 
 
Figure 33. [1H, 15N]-HSQC spectrum of 
ponA2-PASTA 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34. Solution structure of ponA2-PASTA (20 structures) 
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The 3D structure of PonA2-PASTA exhibits the typical PASTA topology, consisting 
of a N-terminal α-helix followed by a three strand β-sheet with β1β2β3 
arrangement. Interestingly, superposition of the NMR structure of PonA2-PASTA 
with other available structures shows a higher structural similarity with PASTA 
domains of STPKs than to that of PBP2x. This finding well correlates with the 
lower sequence identity with PBP2x than with PASTA domains belonging to 
STPKs. Despite this, PonA2-PASTA holds a characteristic feature of PBPs. Namely, 
like in PBPs the loop region between β1 and β2 strands is 4-5 residue shorter 
than in STPKs. 
II.4.8 Binding studies of ponA2-PASTA to muropeptides and β-
lactam antibiotics 
It is well known that the cross peaks distribution in protein [1H-15N] HSQC maps 
(Figure 32) represents an efficient way to detect structural changes in response 
to various phenomena such as molecular binding. In order to test the possible 
ability of PonA2-PASTA to interact with antibiotic molecules and/or PG 
fragments, we performed titrations with 
the two β-lactam antibiotics cefuroxime 
and cefotaxime (Sigma-Aldrich) and 
with synthetic Tri-DAP (InvivoGen), a 
molecule typically used to mimic the PG 
peptide stem. In all cases, we observed 
no significant chemical shift 
perturbations in the [1H-15N]-HSQC 
spectra upon ligand addition, this 
indicating that PonA2-PASTA is unable to 
bind either β-lactam antibiotics, or Tri-
DAP (data not shown). The same 
conclusions were drawn using ITC 
experiments. An example is reported in 
Figure 35, which shows that no heat 
changes are observed upon titration of 
ponA2-PASTA with mur-TriDAP. 
 
 
Figure 35. ITC experiment of 
ponA2-PASTA (0.15mM) with 
mur-TriDAP (15mM) 
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II.5 CONCLUSION 
Muropeptides are a clear molecular signal that growing conditions are 
promising, since they are produced during cell wall PG remodeling associated 
with cell growth and division of neighboring bacteria. However, whether 
muropeptides are able to bind the protein physically and how the extracellular 
region is able to distinguish between different muropeptide types was unclear. 
We focused our attention on STPK PrkC from Staphylococcus aureus and from 
Bacillus subtilis and on a PBP from MTB, denominated ponA2. The fil rouge 
between these proteins is that they are all involved in regulation of 
resuscitation from bacterial dormancy and they all contain PASTA domains. 
To this end, we conducted structural studies on PrkC from Staphylococcus 
aureus and from its homologue Bacillus subtilis. Furthermore, here we tackled 
the important question of how the extracellular region of PrkC from B. subtilis 
senses muropeptides. By coupling crystallography, bioinformatic, protein 
mutagenesis and ITC we proved that EC-PrkC B.s is able to bind DAP-type 
muropeptides and investigated the structural requirements necessary for 
recognition and binding. We have also shown that this recognition occurs 
through interactions of DAP with Arg500, as a mutation of this amino acid in 
EC-PrkC completely impaired muropeptide binding. This finding well agrees 
with the key role played by arginine in the specific recognition of DAP-type 
muropeptides by PG recognition proteins (Shah and Dworkin J., 2010; Shah et 
al., 2008). In this scenario, the key role of Arg500 in binding provides a clear 
explanation for the ability of EC-PrkC from B. subtilis to discriminate between 
DAP- and Lys-type muropeptides in bacterial revival. Using this mechanism, B. 
subtilis bacteria, which possess a DAP-type PG, can cross-talk and trigger 
resuscitation by its own cell wall turnover. Our data provide the first molecular 
clues into the mechanism of sensing of muropeptides by PrkC. These findings 
opened a novel and more complex scenario in the interpretation of the 
mechanism of bacterial revival from dormancy. In this scenario, hydrolysis of 
the cell wall by hydrolases (like RipA in MTB) is only the first step, that has the 
twofold effect to alter the mechanical properties of the cell wall and produce 
specific PG fragments.  
With the aim of investigating whether a similar muropeptide sensing 
mechanism is mediated by the PBP PonA2, we determined the NMR structure 
of its PASTA domain. Beside elucidating the structural properties of this domain, 
our main interest was to understand if this domain may be a possible target for 
  
65 
 
muropeptides or β-lactam antibiotics. Indeed, it was previously shown that the 
the β-lactam antibiotic cefuxomine binds a PASTA domain of the PBP2x from S. 
pneumoniae, which contains two C-terminal PASTA domains (Gordon et al., 
2000; Dessen et al., 2001). Using NMR titration and ITC experiments, we show 
that PonA2-PASTA is unable to bind the PG fragment mur-TriDAP, different than 
what we observed for PrkC. Similarly, we found that PonA2-PASTA does not 
bind the β-lactam antibiotics cefuxomine and cefatoxime. Although the 
importance of this domain in PonA2 function is still to be clarified, our results 
point to a structural role and not necessarily a muropeptide sensing role. 
Consistent with our findings, we observed that only one PASTA domain of PrkC 
is involved in muropeptide binding. 
PASTA-containing proteins have been often proposed as interesting targets for 
β-lactam antibiotics, to be considered in the future for the design of new 
antimicrobials as well as anchors for muropeptides. Our work shows that this 
role of PASTA domains, which were considered as ‘β-lactam binding domains’ 
(Yeats et al., 2002) cannot be generalized. Although our NMR structure 
confirms that the PASTA fold is highly conserved (Figure 33), sequence identities 
among PASTA domains can be as low as 5%. Therefore, specific properties of 
PASTA domains as β-lactam or muropeptide binders strongly depend on 
surface residues, which are widely variable.  
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Table 1. Statistics of data collection for RipA263-472 and SeMetRipA263-472 
 
 SeMet derivative  Native 
 Peak 
 
Inflection point 
 
Remote 
 
 
Beamline BM14 BM14 BM14 BM14 
Space group P212121 P212121 P212121 P212121 
Unit cell parameters (Å)   
a 36.83 36.83 36.83 36.77 
b 65.84 65.76 65.77 65.41 
c 67.84 67.86 67.87 67.79 
Resolution (Å) 1.35 1.35 1.52 1.00 
Wavelength (Å) 0.979 0.979 0.946 0.974 
Average  
Redundancy 
11.6 (4.0) 10.7 (7.0) 4.6 (4.3) 12.2 
 
Unique reflections 35146 35658 26106 85882 
Completeness 95.3 
(73.0) 
96.4 (75.9) 99.9 (100.0) 96.5 
(72.6) 
Rmerge (%) 7.5 (17.1) 5.9 (16.3) 5.0 (10.1) 8.0 
(29.2) 
Average I/σ(I) 58.7 (7.4) 54.5 (9.2) 55.8 (21.3) 19.7 
(3.0) 
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Table 2. Data Collection and Rifinement statistics of RipA263-472 
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Table 3. Data collection and refinement statistics. Values in parentheses are for 
the highest resolution shells (1.00-0.97 Å and 1.43-1.39 Å for C383A and H432A 
mutants, respectively) 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 RipA263-472C383A RipA263-472H432A  
 
A. Data collection 
  
Space group P212121 P212121 
Cell parameters a,b,c (Å);  36.76,  65.51, 67.98   36.70, 65.49, 68.33 
Resolution range (Å) 30-0.97 30-1.39 
N. of unique reflections 97211 32925 
Average redundancy 8.9 (6.4) 5.0 (3.5) 
Rmerge (%) 5.4 (45.0) 4.8 (9.0) 
Completeness (%) 99.4 (99.9) 98.8 (90.0) 
Mean I/σ(I) 43.8 (2.9) 61.0 (15.1) 
   
B. Refinement   
Rwork / Rfree (%) 14.4/18.2 16.9/18.5 
   
Bond lengths (Å) 0.01 0.01 
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Table 4. Data collection and refinement statistic of EC-PrkC from S.aureus 
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Table 6. Protein Structure Violation Suite Statistics for the ensemble of 10 
structures calculated for ponA2-PASTA (residues 703-764) 
 
NOE based distance constraints 
 
Totala 465 
intra-residue [i = j] 189 
sequential [│i - j│ = 1] 133 
medium range [1 <│i - j│ < 5] 38 
long range [│i - j│ ≥ 5] 105 
 
Backbone dihedral angle constraints 87 
 
Total number of constraints 552 
 
Residual constraint violations 
Distance violations/structure  
0.1-0.2 Å 26.4 
0.2-0.5 Å 7.8 
> 0.5 Å 13.3 
RMS of distance violation/constraint 0.13 Å 
Maximum  distance  violation 1.17 Å 
Dihedral angle violations/structure 
1-10° 10.8 
>10° 0 
RMS of dihedral angle violation/constraint 0.74° 
Maximum dihedral angle violation 4.70° 
RMSD Values 
All backbone atoms  0.4 Å 
All heavy atoms 0.8 Å 
Ramachandran plot(%) 
Most favored region 89 
Additionally allowed region 11 
Generously allowed region 0 
Disallowed region 0 
 
aDistance constraints which excluded fixed intra-residue distances. 
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Abbreviations 
CD Circular Dichroism 
CHAP Cysteine Histidine Amino Peptidase 
DA Diamino 
EC Extra Cellular 
EF-G Elongation Factor G 
EF-Tu Elongation Factor Thermo-unstable 
ESRF European Synchrotron Radiation Facility 
FITC fluorescein isothiocyanate 
GlcNAc N-acetylglucosamine 
GST Glutatione S-Transferase 
HSQC Heteronuclear Single Quantum Coherence 
IG Immunoglobulin 
IMAC Immobilized Metal Affinity Chromatography 
IPTG Isopropil β-D-1-tiogalattopiranoside 
ITC Isotermal Titration Calorimetry 
KDa KiloDalton 
LB Luria Broth 
LC-MS Liquid Chromatography-Mass Spectrometry 
LPS Lipopolysaccharides 
LTAs Lipoteichoic acids 
m/z Mass-to-charge ratio 
MAD Multi-wavelength Anomalous Diffraction 
m-DAP meso-diaminopimelic acid 
MDR-TB Multidrug-resistant TB 
MS Mass Spectrometry 
MTB Mycobacterium tuberculosis 
MurNAc N-acetylmuramic acid 
NMR Nuclear Magnetic Resonance 
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NOE Nuclear Overhauser Effect 
NOESY Nuclear Overhauser Effect Spectroscopy 
NTA Nitriloacetic Acid 
OD Optical Density 
OM Outer Membrane 
PASTA PBP and Serine/Threonine kinase Associated 
PBP Penicillin Binding Protein 
PCR Polymerase Chain Reaction 
PDB Protein Data Bank 
PEG Polyethylene glycol 
PFAM Protein Families 
PG Peptidoglycan 
RipA Resuscitation promoting factor Interacting Protein A 
RMSD Root Mean Square Deviation 
RpfB Resuscitation Promoting Factor 
rpm revolutions per minute 
SAD Single-wavelength Anomalous Diffraction 
SAXS Small Angle X-ray Scattering 
SDS Sodium Dodeciyl Sulfate 
STD Saturation Tranfer Difference 
STPKs Ser/Thr protein kinases 
TAs Teichoic Acids 
TB Tuberculosis 
TEV protease Tobacco Etch virus protease 
TFA Trifluoroacetic Acid 
Tm melting temperature 
TOCSY Total Correlation Spectroscopy 
TRX Tioredossina 
WHO World Health Organization 
WTAs Wall Teichoic Acids 
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Standard amino acid abbreviations 
Alanine Ala (A) 
Arginine Arg (R) 
Asparagine Asn (N) 
Aspartic Acid Asp (D) 
Cysteine Cys (C) 
Glutamine Gln (Q) 
Glutamic Acid Glu (E) 
Glycine Gly (G) 
Histidine His (H) 
Isoleucine Ile (I) 
Leucine Leu (L) 
Lysine Lys (K) 
Methionine Met (M) 
Phenylalanine Phe (F) 
Proline Pro (P) 
Serine Ser (S) 
Threonine Thr (T) 
Tryptophan Trp (W) 
Tyrosine Tyr (Y) 
Valine Val (V) 
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